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Placental abruption, the premature detachment of the placenta, before birth and after 20 
weeks gestation, occurs in 0.6% -1% of all pregnancies in the United States. Little is 
known about the duration of labor or the risk of neonatal morbidities attributed to 
abruption. This study examined labor duration, delivery mode, and neonatal outcomes 
associated with placental abruption among singleton pregnancies in the Consortium on 
Safe Labor study (n=223,252), a retrospective, observational study of deliveries from 
2002-2008 in 19 U.S. hospitals. Models were fit using generalized estimating equations 
controlling for maternal age, race, pre-pregnancy BMI, insurance, history of cesarean, 
marital status, and study site (cervical dilation, birthweight, and gestational age were also 
included for labor and delivery analyses). Labor duration was modeled for each of the 
three stages and calculated separately by parity (nulliparous or multiparous) and labor 
type (induced or spontaneous). 
Abruption was associated with elevated risk of cesarean delivery among both 
nulliparous (RR=1.67, 99% CI: 1.54, 1.80) and multiparous women (RR=1.49, 99% CI: 
 
 
1.38, 1.59). Abruption was not associated with differences in stage 1 or stage 2 labor in 
any group, but was associated with a shorter duration of stage 3 labor among multiparous 
women with spontaneous labor ((exp) β = 0.9, 99% CI: 0.8, 0.9) that was not clinically 
meaningful (1 minute). Abruption was associated with elevated risk of neonatal 
interventions including newborn resuscitation (RR=1.54, 99% CI: 1.48, 1.61) and longer 
Neonatal Intensive Care Unit Length of Stay (NICU LOS) (IRR=1.98, 99% CI: 1.83, 
2.14), as well as morbidities and mortality including  respiratory distress syndrome (RR= 
7.40, 99% CI: 6.77, 8.04), apnea (RR=6.63, 99% CI: 5.86, 7.40), asphyxia (RR=8.96, 
99% CI: 6.06, 11.85) and perinatal death (RR=7.29, 99% CI: 5.87, 8.70). With the 
exception of NICU LOS among term and non-low birthweight neonates, all associations 
remained significant regardless of the timing of abruption, gestational age, birthweight, or 
delivery mode. 
Contrary to prior studies, abruption was not associated with shorter duration of 
labor. Abruption was associated with increased morbidity among surviving neonates, 
which adds to the burgeoning literature highlighting the importance of placental 
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Placental abruption, the premature detachment of the placenta from the uterine 
wall, before birth and after 20 weeks gestation, occurs in 0.6% -1% of all pregnancies in 
the United States.
1,2
 It typically presents with maternal symptoms of vaginal bleeding, 
abdominal pain and contractions and can result in abnormal fetal heart rate tracings.
2
 In 
severe cases it can rapidly progress to significant maternal blood loss, fetal hypoxia and 
fetal death, and necessitate emergent cesarean delivery.
3,4
 Much of the scientific literature 
has focused on maternal outcomes, but relatively little is known about labor and delivery 
outcomes such as duration of labor and mode of delivery associated with abruption.   
The disorder is characterized by placental dysfunction which, with progression, 
can lead to a decrease in the surface area available for oxygen exchange and nutrient 
supply.
5,6
 This process can lead to an elevated risk of low birthweight, prematurity, low 
Apgar scores and perinatal mortality.
1,3,7
 It remains uncertain whether abruption also 
increases the risk of other adverse neonatal outcomes associated with hypoxia and 
prematurity such as asphyxia, hypoxic-ischemic encephalopathy (HIE), respiratory 
distress syndrome and apnea.
8-11
   
Lastly, for neonates who initially survive the delivery, little is known about the 
need for and extent of medical interventions utilized, such as admission to neonatal 




This study investigated labor, delivery, and neonatal outcomes associated with placental 
abruption. Specifically, I  
1) Determined whether the duration of labor and the mode of delivery are 
different among women with placental abruption compared to women without 
abruption. 
2) Determined whether neonatal admission to NICU, duration of stay in the 
NICU, and use of newborn resuscitation are different among women with 
placental abruption compared to women without abruption.  
3) Determined whether the risk of neonatal outcomes associated with hypoxia 
and prematurity are different among women with placental abruption 





Placental Development and Functioning 
During pregnancy, the placenta supports the growing fetus through provision of 
nutrition, immune and endocrine regulation, gas exchange and elimination of waste 
products. The cells that will develop into the placenta, called trophoblasts, form only a 
few (4-5) days after fertilization of the egg and begin to produce human chorionic 
gonadotropin (hCG).
12-17
 HCG triggers endometrial changes which allow the fertilized 
egg to implant and also initiates a complex chemical signaling interaction that culminates 
in the developing placenta attaching to the lining of the uterus. Initially high levels of 
hCG released during the creation of the placenta result in the formation of shallow, 
surface-level attachments to the lining of the uterus. After the first two weeks of 
gestation, the hormone levels begin to decline and this triggers the placenta to transition 
to developing deeper attachments to the uterine lining, resulting in a firm connection to 
the maternal blood supply.
12
 By 18-20 weeks of gestation, the placenta (now a pancake-
shaped organ), has grown to its full length of approximately 22 cm (8.5 inches) in 
diameter, but the width will continue to expand approximately 1 mm per week during the 
pregnancy. At birth, the placenta weighs roughly 470 g (1 pound) and is between 2.0-2.5 
cm (1- 1.5 inches) thick.
13,14,18,19
 It is worth noting that although the actual placenta itself 
is only 22 cm in diameter at term, the end-to-end surface area created by the finger-like 




 The placenta detaches after birth, during what is termed the third stage of labor.
21
  
Detachment typically results from the shearing forces that occur as labor contractions 
continue and the uterus begins to shrink following delivery. Separation can also occur 
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when contractions cause vascular rupture within the placenta-uterine attachment site; the 
pooling blood causes increasing pressure between the maternal and fetal interface and 
forces the placenta to detach from the uterine wall.
21
   
Pathologic partial or complete placental separation from the uterine wall can also 
occur. Prior to 20 weeks gestation, placental separation is considered either a miscarriage 
or a threatened miscarriage (i.e., vaginal bleeding, but no pregnancy loss) because the 
fetus has not yet reached the point of viability. The incidence of placental separation 
occurring prior to 20 weeks gestation is unknown. Many very early miscarriages are 
missed entirely (mistaken for monthly menstruation) and among those that are 
documented, it is often unclear whether it resulted from an abnormal pregnancy or 
placental separation.
22
 However, early (<20 weeks gestation) vaginal bleeding during 
pregnancy is associated with a 1.6 fold increased risk of abruption; this risk nearly 
doubles if there is bleeding during both the first and second trimesters.
23
 It is possible that 
some of the cases of early vaginal bleeding were abruptions that began very early in 
pregnancy. However, the diagnosis of abruption in this particular study was classified at 
the time of delivery so it is difficult to determine whether these are early abruptions that 
bleed throughout pregnancy or if the early bleeding serves as a warning of increased risk 
for an abruption occurring later in pregnancy. 
Placental separation after 20 weeks of gestation and prior to the third stage of 
labor, termed ‘placental abruption,’ is the focus of the current study and occurs in 0.6% - 
1% of all pregnancies in the United States.
1,2




Classification of Abruption 
 Cases of abruption can be classified as Grade I (mild) when a woman presents 
with minimal bleeding and uterine irritation, normal blood pressure and no fetal distress 
or evidence of maternal shock.
24,25
 This diagnosis is typically based on the finding of a 
small placental clot at the time of delivery. Women are classified with Grade II 
(intermediate) abruption when presenting with greater vaginal bleeding, uterine 
hypertonicity, increased maternal heart rate and fetal distress, but no evidence of maternal 
shock.
25
 The vast majority of abruption cases are considered either mild (40%) or 
intermediate (45%) in severity. Grade III (severe) abruption occurs in 15% of all cases 
and typically presents with significant bleeding, constant contraction of the uterus (tetanic 
uterus), evidence of either maternal shock or coagulation defect (thrombocytopenia or 
hypofibrinogenemia), and fetal death.
24,25
 It is important to remember that an abruption 
may initially present with a small separation, but can rapidly progress to greater 
separation and maternal-fetal decline.   
Although it is not explicitly addressed in the severity classification described 
above, the degree of placental separation is certainly a major factor in the clinical 
presentation. The placenta may partially separate from the uterine wall or it may detach 
completely, but separation of more than 50% of the placental area is associated with a 
high risk of fetal death and significant maternal morbidity.
24
 Total separation is 
associated with the worst prognosis for both mother and neonate, but this most severe 
form occurs in only 7% of abruption cases and only 0.2% of all pregnancies.
26,27
 
Although infrequently reported, estimates of the distribution of cases by degree of 
separation suggest that the majority (54%) have less than a 25% separation, the remainder 
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are evenly divided with 16% having between 25-50% separation, 13% having between 
50-74% separation and 17% having more than 75% separation.
7,28
  
 The diagnosis of the abruption relative to the duration of pregnancy is also an 
important distinction in case classification. Abruption more frequently occurs earlier in 
gestation, with a peak of about 9/100 births between 24-26 weeks gestation and then 
steadily declines with each successive week. By 32 weeks, only 5/100 births are affected 
and by 36 weeks only 1/100 births have an abruption.
29
 In a Finnish study, more than half 
(59%) of women with abruption delivered preterm.
26
 Abruption occurring preterm may 
more frequently be the result of acute, inflammatory processes (e.g. trauma, infections, 
premature rupture of membranes), whereas abruption occurring at term is thought to be a 
mixture of both acute and chronic processes (e.g. vascular dysfunction associated with 
conditions like diabetes and smoking).
30
   
Diagnosis of abruption relative to the onset of labor is another important 
distinction. Between 50-75% of cases occur prior to the onset of labor (antepartum), with 
roughly 25-50% occurring during labor (intrapartum).
26,31
 Only one previous study has 
reported outcomes separately for antepartum and intrapartum abruption and in that 
instance, both emergency cesarean and admission to the NICU were higher among cases 
of abruption that occurred antepartum.
32
 It is reasonable to suspect that intrapartum 
abruption may involve more of a mechanical/traumatic force as the uterus is actively 
contracting, but the other previously described chronic and acute risk factors may 
increase the vulnerability of the placenta to these forces. The lack of literature on this 
particular topic may be due to the difficulty in distinguishing the timing of the abruption. 
Antepartum abruption is more easily distinguished because the abruption occurs prior to 
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the onset of labor, but cases that are identified during labor could potentially be 
misclassified. It is possible that these abruptions began earlier in pregnancy, but were not 
detected until the onset of labor. It would seem reasonable that a woman experiencing an 
antepartum abruption that subsequently resolves may also experience an intrapartum 
abruption in the same pregnancy 
 Lastly, there is evidence to suggest that abruption occurring in the first pregnancy 
may have a different risk pattern compared to abruptions that occur for the first time in 
subsequent pregnancies.
33
 Specifically, when stratified by parity, smoking duration, and 
presence of placental infarcts have been associated with increased risk of abruption in 
second pregnancy but not the first pregnancy.
33
 However, this study grouped together 
women with a history of abruption as well as those without a history of abruption in the 
second pregnancy group. The established differences in risk between women with a 
history of abruption versus those without make the interpretation of these findings 
difficult.  
Risk Pathways for Abruption 
Although there are a variety of risk pathways, cases can initially be separated into 
acute versus chronic cases. Maternal abdominal trauma resulting from a fall, car accident 
(seatbelt worn incorrectly across the abdomen or sudden deceleration), or physical abuse 
can lead to an acute antepartum abruption. The elastic tissue within the uterus can 
undergo slight changes in shape to absorb a blow or a sudden change in pressure, but the 
placenta has no such elasticity and therefore undergoes a shearing force in such 
circumstances.
24
 Maternal trauma from car accidents is estimated to account for 1-2% of 
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all severe abruptions; however, it is noteworthy that abruption occurs in 40-50% of all 
life-threatening maternal traumatic injuries.
34
   
Acute abruption can also occur in the postpartum period in the context of multiple 
gestation pregnancies. Delivery of the first neonate leads to a rapid loss of fluid and 
sudden decompression of the uterus, which generates a shearing force on the placenta 
(similar to the natural detachment during third stage of labor) causing it to detach from 
the uterus before all of the neonates have been delivered.
24
 However, there are also 
documented differences in risk factor profiles for singleton versus twin gestation cases of 
abruption.
35
 One study found that chronic hypertension and pregnancy-induced 
hypertension are risk factors for abruption in singleton pregnancies, but not twin 
pregnancies.
35
 The explanation for why the same risk factors would have a different 
impact depending on the number of fetuses being carried is not currently known, but it 
may be that the increased placental area that occurs in multiple gestations somehow 
better compensates for oxygen/nutrient deprivation. Altogether, multiple gestation is 
associated with a 1.5-3.0 fold elevated risk of abruption compared to singleton 
pregnancies.
24
   
Similarly, premature rupture of membranes (PROM) (associated with a 1.8-5.1 
fold increased risk of abruption) can also result in a sudden, dramatic decrease in 
amniotic fluid and decompression of the uterus which can generate the same shearing 
force.
24,36
 Abruption can take place in up to 50% of PROM cases that occur prior to 20 
weeks gestation and up to 44% of PROM cases that occur between 20-24 weeks 
pregnancy.
37
 Lastly, use of cocaine and other central nervous system stimulants during 
pregnancy is associated with 5.0-10.0 fold elevated risk as they can result in a 
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combination of sudden increased blood pressure and constriction of the blood vessels in 
the placenta, which can lead to a large, acute abruption.
24
  
 Chronic cases of abruption are largely attributed to processes that interrupt or 
weaken the vascular attachment between the placenta and the uterine wall. Women with 
certain genetic conditions that affect coagulation tend to have higher incidence of 
abruption.
24,38-40
 Specifically, women with either inadequate levels of the clotting factor 
fibrinogen (hypofibrinogenemia) or dysfunctional fibrinogen (dysfibrinogenemia) are 
predisposed to abruption.
40,41
 Among these women, even a small placental separation can 
lead to prolonged bleeding under the placenta and the force exerted by the pooling blood 
pushes the placenta off of the uterine surface. Hypofibrinogenemia is a rare disorder, but 
an estimated 8%-15% of Caucasian women are carriers of a thrombophilia gene.
39,42
 On 
the opposite end of the spectrum, women who have disorders in which their blood clots 
too easily (thrombophilias) are also predisposed to abruption. It has been hypothesized 
that thrombophilia can lead to clots forming in the placenta, blocking blood flow and 
causing tissue damage, which weakens the placental attachment to the uterine wall.
24,38
 It 
has been suggested that undiagnosed or, as of yet, undiscovered genetic markers may be 




 Advanced maternal age (>35 years) and increasing parity have also been 
documented as risk factors for abruption (1.1-3.7 fold increased risk), but as they are 
inherently intertwined, it is unclear whether both independently increase risk. Studies of 
these two factors have frequently yielded conflicting results, with some finding 
significant risk with parity, but not advanced maternal age and others finding the opposite 
10 
 
and still more finding no significant association with either factor.
24
 The explanation for 
why there is elevated risk in this setting has not been established in the literature, but 
given the nature of the other risk factors, it is reasonable to suspect compromised uterine 
vasculature. 
43
    
Preexisting chronic hypertension (1.8-5.1 fold increased risk), pregnancy-induced 
hypertension (PIH) (2.5 fold increased risk) and preeclampsia (0.4-4.5 fold increased 
risk) have all been associated with increased risk of abruption, but the exact nature of this 
association has not been established.
24,44
 It may be that underlying systemic vascular 
disease is responsible for all of these conditions. However, it has also been suggested that 
PIH and preeclampsia may be manifestations of chronic placental disease or earlier 
dysfunction at the time of trophoblast invasion of the uterine lining, which may then 
increase risk of abruption.
24,44-46
 Both maternal and paternal smoking are also associated 
with abruption (with an additive risk if both parents smoke), likely due to the chronic 
hypoxia and vasoconstriction which lead to tissue damage and weaken the attachment 
site.
26,45
 There also appears to be a synergistic interaction between hypertensive disorders 
and smoking for risk of abruption: non-smokers with chronic hypertension had a 2.29 
fold increased risk of abruption, smokers who were normotensive had a 1.96 fold 
increased risk, but smokers with chronic hypertension had a 4.66 fold increased risk.
35
 
Both smoking and gestational diabetes also alter the production and availability of 
prostaglandins that are manufactured within the umbilical vessels. These prostaglandins 
serve both as vasodilators and clotting inhibitors, so a decline in production could 
potentially increase the risk of clot formation and placental infarcts, resulting in placental 
damage.
20
 Alcohol consumption can also cause disruption to the rather delicate maternal-
11 
 
fetal hormonal balance and vasoconstriction in both the umbilical cord and placenta 
which can lead to an abruption.
47,48
 Infection of the fetal membranes (chorioamnionitis) 




Lastly, a history of abruption is associated with as much as a 20-30 fold increased 
risk of abruption in a subsequent pregnancy, but it is likely that this phenomenon is 
simply capturing underlying, unknown risk factors in the previous pregnancy that are 
continuing to be present in subsequent pregnancies. 
24
 Recurrence risk after first episode 
ranges from 6-17% and increases to 25% if there have been two episodes.
27
 
 Nutritional deficiencies during pregnancy can lead to poor placental development, 
which may explain why a lower pre-pregnancy body mass index (BMI) and inadequate 
weight gain during pregnancy have been associated with a 0.9-2.0 fold increased risk of 
abruption.
50,51
 Similarly, the association between both single marital status and Medicaid 
use with the risk of abruption is thought to largely be a reflection of access to resources.  
Lack of adequate nutrition and prenatal care can result in poor management of various 




Abruption also occurs more frequently among African-American women. 
However, there is a particular pattern where, compared to white women, there is a greater 
risk of abruption in term pregnancies, but not preterm pregnancies. This suggests that the 
association may be attributed to chronic risk factors more prevalent among African-





Overall, there have been increases in the incidence of abruption over the last few 
decades in the U.S., with notable differences between black and white women. For black 
women, the incidence increased from 0.76% from 1979-1981 to 1.43% from 1999-2001. 
Although the overall percentage is still low, this change in incidence represents a 92% 
increase.
24
  The incidence among white women increased only 15%, from 0.82% during 
1979-1981 to 0.94% in 1999-2001.
24
 In contrast to the U.S., Scandinavian countries have 
reported decreasing incidence of abruption. In Finland, the incidence has gone from 
0.49% in 1980 to 0.34% in 2005.
1,54
 It is possible that the increasing rate of abruption in 
the U.S. is due to changes in the risk profile of women giving birth in this country. 
Factors associated with abruption have increased over this same period of time including: 
anemia during pregnancy, gestational diabetes, and gestational hypertension, as well as 
behavioral risk factors such as smoking and drug use during pregnancy.
52,55
 There is also 
some evidence to suggest that the true incidence of abruption may be much higher than 
currently reported as subclinical cases are not always detected. A large study of 7,038 
pregnancies identifying cases through pathological examination found an abruption 
incidence of 3.8%, which is considerably higher than the typically presented 1%.
29
 It is 
unknown whether these subclinical cases are also associated with poorer neonatal 
outcomes. 
Abruption Outcomes 
 The immediate consequences of the placenta’s detachment from the uterine wall 
are blood loss and reduction in oxygen and nutrient availability to the fetus,  the severity 





The majority (70-80%) of pregnancies with an abruption will present with vaginal 
bleeding to some extent, but the amount of blood loss does not necessarily correlate to the 
degree of placental separation.
26,56,57
 Abdominal pain (27.8%) and uterine hypertonia 
(26.1%) are other frequent maternal symptoms. 
56
 In terms of the fetus, the majority of 
abruption cases (64.8%) present with non-reassuring fetal heart tracing (NRFHT), but 
more severe cases may present with fetal death.
56,58,59
  
The main maternal outcome of concern is blood loss, which can be significant and 
can rapidly progress to disseminated intravascular coagulopathy (DIC). This aggressive 
coagulation response can lead to extensive, system-wide clot formation as the maternal 
body attempts to control the uterine bleeding.
29
 Clots travel to the organs and block blood 
flow, which leads to organ damage and multi-system organ failure. As this coagulation 
response continues, the clotting factors in the bloodstream are exhausted (this condition is 
also called ‘consumptive coagulopathy’ for this reason), and massive blood loss and 
hemorrhagic shock can occur.
29
 Approximately 15% of women with abruptions will 
require a blood transfusion and 7-10% will develop a coagulation disorder. However, 
only 6% will experience DIC and only 2.9% will experience hemorrhagic shock.
4,27,56,60
  
Post-partum hemorrhage also complicates roughly 12% of abruption cases.
56
 In cases 
where bleeding cannot be controlled, emergency hysterectomy may be necessary (0.4% 
of all cases).
4
   
Uterine bleeding and coagulation factors released in response to the bleeding can 
both cause the uterus to contract.
27
 Abruption typically presents with high-frequency, 
low-amplitude contractions but it can progress into labor contractions or, alternatively, 





contractions can also exacerbate the abruption by causing more of the placenta to shear 
off, which will lead to more bleeding, pushing the placenta further off the uterine surface 
and irritating more uterine tissue, generating a self-perpetuating cycle.    
Given the partial separation of the placenta and the uterine contractions that are 
typically present in abruption, it is generally thought that labor (especially the third stage) 
progresses more rapidly than usual, but the duration of each stage of labor has not been 
documented. Two studies found a significant association with abruption and a total labor 
duration less than 3 hours (precipitous labor); in one case, there was more than 30 fold 
increased risk.
61,62
 However, these studies were based on small numbers (n=99 each) of 
precipitous labor subjects, with very few cases of abruption within these groups (n=10 
and n=6), and did not control for important confounding factors such as maternal age and 
parity (or did not control for any variables at all).
61,62
 An elevated incidence of 
precipitous labor is of concern because this phenomenon is linked to a higher risk of 
uterine rupture, post-partum hemorrhage, retained placenta, need for transfusion and 
prolonged hospital stay for the mother.
61
  
 Abruption is also associated with a considerably higher rate of cesarean delivery 
(ranging from 67.7% to over 90%), but most of these reports have been in countries 
where medical practice and the demographics of the women giving birth are different 
from those in the U.S.
4,26,56,58-60,63
 Cesarean delivery is associated with the typical short 
term risks associated with all major surgeries (blood loss, infection, damage to 
surrounding structures, etc), but it is also associated with increased risks in subsequent 





 Previous cesarean delivery also increases risks of preterm birth, small for 
gestational age, low birthweight, and stillbirth for the neonate.
65,66
 
Placental abruption has much more frequent and severe consequences for the 
fetus because, in addition to the acute blood loss, separation of the placenta restricts or 
removes the fetal oxygen and nutrient supply. On average, these neonates are born 3-4 
weeks earlier and weigh 200-500 grams less than in pregnancies without abruption.
67
 
Specifically, between 40% -59.4% are born prior to 37 weeks gestation and 8.1% - 65.1% 
are born growth restricted (low birthweight).
4,7,26,31,59,60,68
 Many of these preterm births 
are attributed to spontaneous preterm labor rather than a medically indicated preterm 
birth and it has been suggested that some idiopathic preterm births might actually be due 
to undetected placental abruption.
7
 A separation of even one fourth of the placenta is 
associated with a 5.5 fold increased risk of preterm birth.
7
  In the past, it was assumed 
that the association between abruption and low birthweight was mostly due to the large 
percentage of neonates born prematurely. However, after adjustment for gestational age 
as well as other confounding factors, abruption still associated with a 4.6 fold increased 
risk of low birthweight.
7
 
The few studies that have examined morbidities associated with prematurity and 
hypoxia report elevated risk of intraventricular hemorrhage (17.5%-72%), respiratory 
distress syndrome (40%), and birth asphyxia (47.5%).
1,58,59,67
 There is also often a greater 
need for medical intervention: assisted ventilation is required in 30% of cases and 20% 
are admitted to the neonatal intensive care unit, with an average length of stay of 8.4 
days.
1,31,59,60,69,70
  In an Iranian study of risk factors necessitating resuscitation, 25.9% of 
abruption cases required basic resuscitation and 18.5% required advanced resuscitation.
71
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However, these studies had small numbers of abruption cases (ranging from n= 27 to 
n=103), were conducted among non-U.S. populations (United Kingdom, Iran, Finland, 
Thailand and Italy), and typically examined only one or two of the outcomes discussed 
above. The small numbers of abruption cases reported in these studies make it difficult to 
evaluate the accuracy of these neonatal morbidity estimates. Furthermore, given the 
differences in obstetric populations and medical practices in these countries compared to 
the U.S., the generalizability of the estimates to a U.S. population may also be 
questionable.
1,31,59,60,69,70
 Neonates with respiratory distress syndrome (RDS) have an 
elevated risk of long-term complications that are due to the associated treatment, 
including damage to the lungs and brain from too much oxygen or pressure from 
mechanical ventilation.
72
 Perinatal asphyxia has been found to be associated with a range 
of poor long term outcomes (dependent on severity of asphyxia) including: hypoxic-
ischemic encephalopathy (HIE; brain injury due to oxygen deprivation), cerebral palsy, 
mental retardation, epilepsy, attention deficit – hyperactivity disorders, schizophrenia, 
and development of psychotic disorders in adulthood.
73
 
Abruption is also associated with a high risk of perinatal mortality ranging from 
6.5%-60% of all cases, much of which occurs prior to birth (stillbirth). 
4,26,31,60,68
 This 
translates to an 8.9 fold increased risk of stillbirth and a 15-19 fold increased risk of death 
overall compared to pregnancies without abruption.
7,68
 More than half (55%) of perinatal 
deaths associated with abruption can be attributed to preterm birth, but the increased risk 
of perinatal mortality remains significant even after adjusting for preterm delivery and 
growth restriction. In one study, neonates in pregnancies complicated by abruption that 
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were born at normal weight and full term still had a 25-fold increased risk of mortality 
compared to neonates in pregnancies without abruption. 
68
  
Finally, there are also long-term risks associated with abruption. In a study of low 
birthweight cases of abruption, 11.1% of the neonates born were later diagnosed with 
cerebral palsy, and increased incidence of sudden infant death syndrome (SIDS) has also 
been observed.
1,59
 Two of the most frequently reported outcomes of abruption, low 
birthweight and preterm birth, are also associated with increased risk of disease in 
adulthood. In particular, hypertension, type II diabetes and coronary artery disease have 
been associated with growth restriction during pregnancy 
74,75
 Chronic lung and kidney 
disease, hypertension, and cardiovascular disease, as well as general increased risk of 
mortality in childhood and young adulthood are all associated with preterm birth.
76-79
 
In conclusion, placental abruption is a major risk factor for preterm birth, low 
birthweight and perinatal mortality. However, labor and delivery characteristics as well 
as many important neonatal outcomes have remained understudied. Examining these 
other outcomes will add to our knowledge of abruption specifically, but it may also 
potentially expand our general understanding of how placental dysfunction and disease 
occur and the consequences thereof. This is an area of growing public health importance 
due to the immediate neonatal morbidity and mortality, as well as the associated long-







Chapter 2: Methods 
  
 
Electronic Medical Records and Variable Coding 
The U.S. began to shift towards adoption of electronic medical records (EMR) 
over the last two decades- partly as a consequence of The Health Information Technology 
for Economic and Clinical Health (HITECH) Act which was part of the American 
Recovery and Reinvestment Act of 2009.
80
 The legislation served as both a support and 
incentive program for organizations to design and implement an EMR system and 
transition existing records over to this system. Converting from paper to electronic 
records offered a number of benefits to the medical and public health communities as 
well as to individual patients. It allows for improved accuracy and centralization of 
records, faster transfer of information between providers, easier tracking of public health 
initiatives such as vaccination and it creates large, automated databases of health 
information that can help guide insurance, medical and public health practices by basing 
decisions on actual information.
80
 
Consortium on Safe Labor Study 
This study utilized data from the Eunice Kennedy Shriver National Institute of 
Child Health and Human Development (NICHD) Consortium on Safe Labor (CSL) 
study. This retrospective, observational study was originally conducted to gather 
extensive information on contemporary labor patterns and explore practices surrounding 
use of cesarean delivery in the U.S. As stated in the protocol, the primary purposes of the 
original study were: “(1) to describe contemporary labor progression in the U.S. 
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population; and (2) to determine when is more appropriate time to perform cesarean 
delivery in women with labor protraction and arrest.”
81
 The study concept and protocol 
were developed by scientists at NICHD and a request for site proposals was released. The 
original sample size calculation called for approximately 200,000 deliveries to have 
adequate power to evaluate differences in perinatal outcomes based on the duration of 
non-progressing labor during the active phase.
81
  
A total of 12 clinical centers containing 19 hospitals (some clinical centers 
included more than one hospital) were ultimately selected based on availability of 
existing EMR data and representation of 9 out of the 12 American College of 
Obstetricians and Gynecologists (ACOG) districts in the U.S. Both public and private 
institutions were included and there were no race or ethnic exclusion criteria. All 
participating sites were required to obtain Institutional Review Board (IRB) approval at 
their institution prior to submitting data to the central data coordinating center (DCC) for 
the study. Since all sites would be reviewing existing EMR data at their location, the 
original NICHD study protocol recommended that all sites apply for their IRB using the 
minimal risk, expedited review category with a waiver of informed consent from the 
individual patients.
81
 Individually identifiable patient information was removed from the 
EMR data and each maternal-neonatal delivery instance was assigned a random database 
identifier to be used for the time frame of the study prior to transfer to the central DCC. 
Once the final, cumulative data file including all site data was completed, all sites were 
instructed to destroy any linking files.
81
 IRB approval was also obtained at the DCC and 
at NICHD; since the study represented a retrospective review of electronic medical 
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records and only deidentified data was sent to NICHD, it was classified as exempt by the 
Office of Human Subjects Research (OHSR) at the National Institutes of Health. 
Most EMRs are completed using a variety of checkboxes and dropdown menu 
selections, with occasional free text areas. The current study utilized a large database of 
EMRs compiled as part of the original CSL study. The original coding of the variables 
selected for the current study is presented in Appendix A.1. It was anticipated that there 
may be some variation in terms of what details are captured in the EMR systems at each 
location, but each participating site was required to have the following available in their 
EMR data: maternal demographics, reproductive history, medical history, prenatal history 
of current pregnancy, labor admission assessment, labor progression, labor and delivery 
summary, maternal postpartum condition, and newborn information.
81
  
Each participating site was first required to create a site-specific data dictionary 
detailing the common and unique elements of their data as well as detailed information 
about the formatting of all variables, which was then sent to the DCC. A common data 
dictionary based on all of the site-specific data dictionaries was created at the DCC and 
was used as the template for data extraction and the main dataset.
81
 Then, each 
participating site was expected to extract their EMR data, de-identify all of the entries, 
and then transfer these records securely to the DCC for processing and combining with 
all of the other site data. Once received at the central site, error and consistency checks 
were performed and records were verified, with any identified errors being resolved in 
collaboration with the sites.
81
 
Although this study captured 9 out of the 12 ACOG districts, it is not considered a 
representative sample of women giving birth in the US. However, it is the largest existing 
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US study to include detailed labor, delivery, and neonatal records. In total, retrospective 
EMR data on 228,668 deliveries occurring from 2002-2008 were collected for the study, 
with 9.5% of women contributing more than one birth during the specified time period. 
The specific number of records contributed by each site was based on the total number of 
deliveries occurring each year during the study review time frame. All deliveries 





This study was limited to singleton pregnancies as multiple gestation pregnancies are 




Placental abruption was parameterized based on the presence of any of the following four 
variables abstracted from patient medical records: 1) prenatal history of antepartum 
abruption, 2) labor and delivery record of intrapartum abruption, 3) cesarean indication 
for abruption, and 4) International Classification of Disease- 9
th
 edition (ICD-9) 
discharge codes for abruption as assigned by the physician and/or medical coder 
reviewing the chart.  
Covariates: 
For duration of labor and mode of delivery outcomes, the following covariates 
were selected due to their established biological association with both abruption and the 
outcomes: maternal age, cervical dilation at first examination, gestational age, 
birthweight, pre-pregnancy body mass index (BMI) and history of cesarean 
delivery.
1,8,50,51,82
  Race, insurance status, and marital status were selected as additional 
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covariates to adjust for socio-demographic characteristics of the subjects. Finally, study 
site was included as a covariate to adjust for possible geographic or site-specific 
variation. Duration of labor was modeled separately by parity (nulliparous vs. 
multiparous) and by type of labor (induced vs. spontaneous) because both of these factors 
are associated with significantly different labor patterns and because separate estimates 
have greater clinical utility.
8,83
 
 For neonatal outcomes and utilization of medical intervention, the following 
covariates were selected due to their established biological association with both 
abruption and the outcomes: maternal age, parity and pre-pregnancy BMI.
8,24,50,51,56,82
  
Race, insurance status, and marital status were selected as additional covariates to adjust 
for socio-demographic characteristics of the subjects. Unfortunately, more accurate 
measures of socioeconomic status, such as maternal education and income level, were not 
available for analysis in this dataset. Finally, study site was included as a covariate to 
adjust for possible geographic or site-specific variation.   
Gestational age, birthweight, and delivery mode are important risk factors for 
many poor neonatal outcomes; however, it is likely that these variables are on the causal 
pathway and serve as intermediates between abruption and the specified neonatal 
outcomes. Controlling for these types of variables can lead to inaccurate risk estimates if 
there is unmeasured confounding between the intermediate and the outcome, creating 
what is otherwise known as collider bias.
84
 In the context of the current study, there is a 
strong likelihood that this phenomenon would occur as there is missing information for 
the potential confounding factors (such as occurrence of chorioamnionitis) in the current 
pregnancy. However, the aim of the current study is to estimate the risk of neonatal 
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outcomes associated with abruption regardless of pathways involved, not to estimate the 
risks independent of preterm birth, low birthweight, and delivery mode. In such cases, it 
is best to not include the intermediate variables (i.e., gestational age, birthweight, and 
delivery mode) in the regression model.
84
   
Nevertheless, it is acknowledged that understanding the direct effect attributed to 
abruption independent of preterm birth, low birthweight, and delivery mode would also 
be informative and to that end, a sensitivity analysis was conducted (see the below 
section for detail).  
Missing Data 
There are two types of missing data in the CSL study: missing by individual and 
missing by hospital. Missing by individual means that the hospital was reporting that 
particular variable, but was missing the information in the individual patient’s EMR; 
whereas, missing by hospital means that the site did not report that variable for any of the 
patients at that site. For the purposes of this study, individually missing information from 
the covariates was completed using multiple imputation techniques. Although there does 
not appear to be a rule of thumb for acceptable percentages of missing data, for the 
purposes of this study, if an individual patient was missing more than 50% of the 
covariates, they were dropped from the analysis. None of the covariates selected for this 
study had information missing by hospital site.   
Multiple imputation of missing covariates was performed using PROC FCS (Fully 
Conditional Specification), which is recommended when the missing data pattern is 
arbitrary and both continuous and categorical variables are being imputed in the same 





 In instances of repeated observations/longitudinal designs, missing data were 
imputed with the dataset in the wide format (one person per row) to account for the 
correlation between observations within person; remaining analysis were performed with 
the dataset converted to the long format (one observation per row). However, in the 
current study, only a small percentage of the women had more than one pregnancy 
captured in the data and the percentage of missing data for most variables was also quite 
small. The initial steps in multiple imputation require a certain amount of existing data to 
begin calculations and with only 10% of the women having more than one pregnancy, the 
total percentage of missing data (90%) was too high to impute values for the subsequent 
pregnancies.
85
 Therefore, the repeated measures structure was ignored during the 
imputation phase, but was accounted for in the analytic phase.  
For the outcome variables, only NICU LOS and neonatal apnea have missing 
information: sites 4 and 8 did not report NICU LOS and site 6 did not report neonatal 
apnea for any of their patients. These sites were dropped from the regression analysis of 
their respective missing variables (and this detail was documented in associated tables). 
Otherwise, the sites were retained for all other outcome analyses. Multiple imputation 
was not performed for outcome variables.    
 Analytic Plan 
Descriptive statistics were reported for demographic characteristics as well as all 
outcome variables. Since approximately 10% of the women included in the study had 
more than one birth recorded during the study period, the statistical assumption of 
independent observations is violated within this data and standard regression models 
would not be appropriate. Generalized estimating equation (GEE) models were fit to 
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estimate the risk of the outcomes of interest, while accounting for these instances of 
repeated observations. An exchangeable within-subject correlation structure was 
specified.
86
   
Continuous variables (i.e., duration of labor, length of NICU stay) were fit with a 
generalized linear model and dichotomous variables were fit using the modified Poisson 
approach with a robust error variance estimator.
87
 Distributions of the duration of labor 
and NICU length of stay variables were assessed for normality prior to modeling. 
Duration of stage 1 labor was approximately normal, but the distributions of stage 2 and 
stage 3 labor durations required a log transformation to achieve normality. The 
distribution of NICU length of stay was fit with a negative binomial model, which is 
appropriate for over-dispersed count data.
88,89
  
The modified Poisson approach was selected for the dichotomous variables 
because estimating relative risk using the traditional log-binomial models has been found 
to result in both inaccurately narrow confidence intervals as well as problems with model 
convergence.
87,90
 The primary purpose of the study is to estimate risk of outcomes 
associated with abruption rather than contribution of covariates; therefore, only saturated 
models (containing all covariates) were fit. See Appendix A.2 for a summarized listing of 
independent and dependent variables and covariates for the specified models. Hypoxic-
ischemic encephalopathy was ultimately excluded from analysis after determining that 
there were too few cases for the regression models to converge. 
Beta coefficients and confidence intervals were estimated for continuous variables 
and relative risk and confidence intervals were estimated for all dichotomous outcomes. 
Stage 2 and stage 3 labor duration betas and confidence intervals were back-transformed 
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using the delta method to obtain estimates based on the original variable scaling.
91,92
 
Since multiple outcomes are being evaluated in this study and there is increased risk of 
Type I errors, the 99% confidence interval were computed and a p-value <0.01 was used 
as the cut-off for determining statistical significance.   
Sensitivity Analysis: Timing of Abruption Relative to Labor 
In Chapter 1 of this document it was noted that the nature of an abruption (and 
possibly the associated consequences) might vary depending on whether it occurs before 
labor (antepartum) or during labor (intrapartum). Therefore, a sensitivity analysis was 
conducted replicating the previously described regression models, but utilizing the 
antepartum and intrapartum abruption variables only, rather than the combined “any 
abruption” variable. The main analyses did not take this approach because the focus was 
on estimating the overall risk of the specified outcomes regardless of timing. The timing 
of abruption relative to onset of labor was also not reported by five of the participating 
sites. Therefore, this sensitivity analysis distinguishing antepartum and intrapartum 
abruption was performed on the reduced sample from the seven remaining sites. This 
analysis still yielded a sample of 145,212 and the additional information will contribute 
to our understanding of the role of the timing of abruption relative to the onset of labor.    
To perform this analysis, risk estimates were generated separately for antepartum 
only (excluding women who were also documented as having an intrapartum abruption), 
intrapartum only (excluding women who also had antepartum abruption), and for cases in 
which both antepartum and intrapartum abruption occurred. These estimates (and the 
generated confidence intervals) were compared to the no abruption group, as well as the 
main study results. A change in the direction of association with the specified outcomes, 
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or a large change in magnitude of association when comparing these estimates would 
provide evidence that the timing of the abruption relative to labor might be an important 
variable to consider when evaluating labor, delivery and neonatal outcomes in future 
studies.  
Sensitivity Analysis: Independent Effect of Abruption 
In order to estimate the effect of abruption independent of preterm birth, low 
birthweight, and delivery mode, an analysis was conducted utilizing one of the accepted 
techniques for handling potential collider bias called ‘conditioning on an intermediate 
with sensitivity analysis.’
84
 This approach assessed the potential impact of unmeasured 
confounding and yielded a range of risk estimates for individuals with low birthweight, 
preterm birth, and cesarean delivery. These estimates were then used to create a ‘bias 
factor’  which was incorporated into equations to generate corrected overall risk 
estimates.
84
 Again, the main purpose of this study was to estimate risk of poor outcomes 
regardless of the particular pathway, but this sensitivity analysis provided additional 
insight into the relative contribution of low birthweight, preterm birth, and cesarean 
delivery in these associations. 
Analyses were performed using SAS version 9.4. This study received an 






Chapter 3: Results 
 
 
Overall, the average maternal age at the time of delivery was 27.6, approximately 
half of the sample (51.9%) was white, non-Hispanic and the majority of the women were 
multiparous (60.2%). The average birthweight was 3,242 grams and gestational age at 
delivery was, on average, 38.3 weeks (Appendix B.1). The incidence of placental 
abruption was 1.6% (n=3,613 cases). Sample characteristics by abruption group are 
presented in Table 1. Abruption cases were less likely to be white (46.5%), and more 
likely to be single (48.8%), multiparous (64.2%), have public insurance (48.5%), and 
have a history of cesarean delivery (26.3%), compared to women without an abruption. 
Neonates in pregnancies complicated by abruption weighed an average of approximately 
800 grams less and were born nearly a month (3.7 weeks) earlier compared to neonates in 
pregnancies not complicated by abruption. Sample characteristics for all sensitivity 




Table 1. Maternal, pregnancy, and neonatal sample characteristics according to placental 





(n=3,613) P value 
Maternal Age, years 
a
  27.6  ± 6.2 27.6  ± 6.4 0.70 
Maternal Race, n (%)      
  White 114,109  (52.0) 1,679  (46.5) <0.001 
  Black 51,282  (23.4) 1,179  (32.6)  
  Hispanic 39,575  (18.0) 580  (16.0)  
  Asian 9,310  (4.2) 107  (3.0)  
  Multi/Other 5,363  (2.4) 68  (1.9)  
Pre-pregnancy BMI 
a
 25.7  ± 6.6 26.0  ± 6.8 0.05 
Insurance, n (%)      
  Private 136,763  (62.3) 1,800  (49.8) <0.001 
  Public 79,158  (36.0) 1,752  (48.5)  
  Self-pay/Other 3,718  (1.7) 61  (1.7)  
Marital Status, n (%)      
  Single 86,217  (39.3) 1,763  (48.8) <0.001 
  Married 133,422  (60.8) 1,850  (51.2)  
Parity, n (%)      
  Nulliparous 87,683  (39.9) 1,292  (35.8) <0.001 
  Multiparous 131,956  (60.1) 2,321  (64.2)  
History of Cesarean, n (%) 
b
      
  No 101,172  (76.7) 1,710  (73.7) <0.001 
  Yes 30,784  (23.3) 611  (26.3)  
Cervical Dilation at First Exam, cm 
a
 3.1  ± 2.1 2.8  ± 2.3 <0.001 
Induction of Labor, n (%)      
  No 143,450  (65.3) 2,674  (74.0) <0.001 
  Yes 76,189  (34.7) 939  (26.0)  
Birthweight, grams 
a
  3255  ± 594 2447  ± 949 <0.001 
Gestational Age, weeks 
a
  38.4  ± 2.3 34.7  ± 4.7 <0.001 
a 
Data are given as mean ± standard deviation 
b




Labor and Delivery Outcomes  
Descriptive statistics and adjusted analyses of labor and delivery outcomes are 
presented in Table 2. Abruption was associated with an elevated risk of cesarean delivery 
among both nulliparous (RR= 1.67, 99% CI: 1.54, 1.80) and multiparous (RR=1.49, 99% 
CI: 1.38, 1.59) women. For vaginal deliveries among nulliparous women, there were no 
significant differences in stage 1, stage 2, or stage 3 labor durations for either induced or 
spontaneous labor. For vaginal deliveries among multiparous women, there were no 
significant differences in stage 1 and stage 2 labor durations for women with either 
induced or spontaneous labor. There was also no significant difference in stage 3 labor 
duration for women with induced labor.  However, abruption was associated with a 10% 
shorter duration of stage 3 labor among multiparous women with spontaneous labor 
[(exp) β= 0.9, 99% CI: 0.8, 0.9]. With a median duration of labor of 5 minutes for the no 




Table 2. Labor and delivery outcomes according to placental abruption status among 
nulliparous and multiparous women 
 
a 
Estimates for nulliparous women adjusted for maternal age, race, pre-pregnancy body mass index, 
insurance, marital status, cervical dilation at first exam, birthweight, gestational age, and study site;  
b
 Relative risk of cesarean delivery estimated with modified Poisson model; 
c
 Among vaginal deliveries;  
d
 Data are given as median, range; 
e
 Beta coefficient estimated with generalized linear model. Estimate is 
interpreted as the average difference in duration of stage 1 labor (in hours) for the abruption group, 
compared to the no abruption group; 
f
 Exponential of the beta coefficient estimated with generalized linear 
model. Estimates can be interpreted as the percentage difference in minutes for the abruption group 
compared to the no abruption group, where coefficients less than “1” represent a relative decrease and 
coefficients greater than “1” represent a relative increase; 
g 
Estimates for multiparous women are adjusted 
for maternal age, race, pre-pregnancy body mass index, insurance, marital status, cervical dilation at first 




Labor and delivery 





Delivery Mode, n (%) 88,975        
  Vaginal  61,815  (70.5%) 629  (48.7%)    





         
  Stage 1 Labor, hrs  16,192 8.4  (0.0-24.0)
 d
 8.9  (0.3-23.0)
 d
 -0.5  (-1.6, 0.5) 
e
 0.17 
  Stage 2 Labor, mins  20,368 60  (1-360)
 d
 40  (1-258)
 d
 0.9  (0.8, 1.1) 
f
 0.18 
  Stage 3 Labor, mins
 
 20,466 5  (1-153)
 d
 5  (1-104)
 d





         
  Stage 1 Labor, hrs  28,361 6.8  (0.0-24.0)
 d
 8.4  (0.0-23.7)
 d
 0.4  (-0.5, 1.2)
 e
 0.24 
  Stage 2 Labor, mins  32,086 58  (1-360)
 d
 31  (1-269)
 d
 1.0  (0.8, 1.1)
 f
 0.05 
  Stage 3 Labor, mins
 
 33,298 5  (1-161)
 d
 5  (1-110)
 d
 1.0  (0.9, 1.1)
 f
 0.32 
     
Multiparous Women 
Labor and delivery 
outcomes N No Abruption Abruption β (99% CI) 
g
 P value 
 g
 
Delivery Mode, n (%) 134,277        
  Vaginal  97,135  (73.6%) 1,209  (52.1%)    





         
  Stage 1 Labor, hrs  25,824 5.9  (0.0-24.0)
 d
 7.7  (0.3-23.2)
 d
 0.2  (-0.5, 0.9)
 e
 0.52 
  Stage 2 Labor, mins  29,435 18  (1-360)
 d
 15  (1-315)
 d
 1.1  (0.9, 1.3)
 f
 0.10 
  Stage 3 Labor, mins
 
 31,170 5  (1-178)
 d
 5  (1-98)
 d





          
  Stage 1 Labor, hrs  43,122 4.7  (0.0-24.0)
 d
 6.6  (0.0-23.6)
 d
 0.0  (-0.5, 0.6) 
e
 0.89 
  Stage 2 Labor, mins  48,656 16  (1-360)
 d
 14  (1-347)
 d
 1.0  (0.9, 1.1)
 f
 0.87 
  Stage 3 Labor, mins
 
 54,609 5  (1-165)
 d
 4  (1-175)
 d





Sensitivity Analysis: Timing of Abruption 
To examine whether timing of abruption influenced my findings, I conducted a 
sensitivity analysis including 175,443 pregnancies with data distinguishing antepartum 
from intrapartum abruption (Table 3). Abruption was associated with elevated risk of 
cesarean delivery regardless of timing for both nulliparous and multiparous women, with 
relative risk ranging from RR=1.32 (99% CI: 1.14, 1.49) for the multiparous women with 
antepartum abruption to RR=2.20 (99% CI: 1.86, 2.54) for the nulliparous women with 
both antepartum and intrapartum abruption.  Among nulliparous women, there were no 
significant differences in stage 1 or stage 3 labor duration regardless of timing.  However, 
in contrast to the main results, antepartum abruption was associated with 30% shorter 
stage 2 labor duration among women with induced labor [(exp) β = 0.7, 99% CI: 0.5, 
0.9]. This estimate translates to a decrease of about 20 minutes in the pregnancies with 
antepartum abruption, assuming the median duration of 68 minutes for pregnancies 
without an abruption. Among multiparous women, there were no significant differences 
in stage 1 or stage 2 labor duration regardless of timing, but women with both antepartum 
and intrapartum abruption had a 10% shorter duration of stage 3 labor duration among 
women with spontaneous labor in the antepartum and intrapartum group [(exp) β =0.90, 
99% CI: 0.8, 0.9]. In sum, this sensitivity analysis suggests that abruption was associated 
with increased risk of cesarean delivery regardless of whether it occurred before or 
during labor.  However, the relationship between abruption and duration of labor differed 





Table 3. Labor and delivery outcomes according to timing of placental abruption among nulliparous and multiparous women 
  Nulliparous Women   
   Antepartum  Intrapartum  
Labor and delivery 
outcomes N No Abruption Abruption β (99% CI) 
a
 P value 
a





Delivery Mode, n  58,170             
  Vaginal  40,524  (70.5%) 191  (59.7%)    131  (62.4%)    
  Cesarean  16,923  (29.5%) 129  (40.3%) 1.57  (1.28, 1.86) 
b





              
  Stage 1 Labor, hrs 10,258 9.0  (0.0-24.0)
 d
 8.9  (3.4-23.0)
 d
 -0.3  (-2.3, 1.8) 
e
 0.75 11.0  (0.3-23.0)
 d
 -1.5  (-4.3, 1.4) 0.18 
  Stage 2 Labor, mins 13,984 68  (1-359)
 d
 38  (1-230)
 d
 0.7  (0.5, 0.9) 
f
 0.01 36  (5-208)
 d
 1.0  (0.7, 1.3) 0.86 
  Stage 3 Labor, mins 13,950 5  (1-153)
 d
 6  (2-70)
 d
 1.0  (0.8, 1.5)
 f
 0.71 6  (1-104)
 d
 1.0  (0.7, 1.5) 0.90 
Spontaneous Labor 
c
              
  Stage 1 Labor, hrs 16,869 8.0  (0-24.0)
 d
 10.2  (0-23.7)
 d
 0.7  (-0.8, 2.2)
 e
 0.22 11.1  (0.4-23.3)
 d
 0.6  (-1.2, 2.5) 0.37 
  Stage 2 Labor, mins 19,393 64  (1-359)
 d
 44  (1-269)
 d
 1.0  (0.8, 1.2)
 f
 0.71 31  (1-240)
 d
 1.0  (0.7, 1.3) 0.67 
  Stage 3 Labor, mins 19,609 5  (1-158)
 d
 5  (1-110)
 d
 1.0  (0.9, 1.3)
 f
 0.55 6  (1-62)
 d
 0.9  (0.7, 1.2) 0.36 
         
  Multiparous Women   
   Antepartum  Intrapartum  
Labor and delivery 











Delivery Mode, n 87,042          
  Vaginal  62,612  (73.1%) 409  (63.2%)    213  (50.8%)    
  Cesarean  22,995  (26.9%) 238  (36.8%) 1.32  (1.14, 1.49) 
b





              
  Stage 1 Labor, hrs 17,847 5.8  (0.0-24.0)
 d
 8.0  (1.7-23.0)
 d
 -0.1  (-1.2, 1.1)
 e
 0.88 10.0  (0.3-23.2)
 d
 1.1  (-1.0, 3.3) 0.17 
  Stage 2 Labor, mins 21,269 20  (1-360)
 d
 15  (1-186)
 d
 1.0  (0.8, 1.3)
 f
 0.68 10  (1-137)
 d
 0.9  (0.6, 1.2) 0.25 
  Stage 3 Labor, mins 22,058 5  (1-178)
 d
 5  (1-98)
 d
 1.0  (0.8, 1.2)
 f
 0.98 7  (1-53)
 d
 1.0  (0.7, 1.4) 0.90 
Spontaneous Labor 
c
              
  Stage 1 Labor, hrs 25,480 5.8  (0-24.0)
 d
 6.5  (0-23.1)
 d
 -0.4  (-1.4, 0.5)
 e
 0.23 8.3  (0.1-23.6)
 d
 1.2  (-0.5, 2.8) 0.08 
  Stage 2 Labor, mins 29,272 19  (1-360)
 d
 17  (1-302)
 d
 1.1  (0.9, 1.3)
 f
 0.39 12  (1-304)
 d
 0.9  (0.7, 1.1) 0.22 
  Stage 3 Labor, mins 30,677 5  (1-158)
 d
 4  (1-88)
 d
 0.9  (0.8, 1.0)
 f
 0.01 5  (1-87)
 d





Table 3. Continued 
  Nulliparous Women   
   Antepartum & Intrapartum  
Labor and delivery 







Delivery Mode, n  58,170        
  Vaginal  40,524  (70.5%) 79  (40.9%)    





         
  Stage 1 Labor, hrs 10,258 9.0  (0.02-24.0)
 d
 4.2  (2.7-16.2)
 d
 -2.3  (-5.4, 0.7)
 e
 0.05 
  Stage 2 Labor, mins 13,984 68  (1-359)
 d
 81  (20-258)
 d
 1.3  (0.7, 2.3)
 f
 0.13 
  Stage 3 Labor, mins 13,950 5  (1-153)
 d
 5  (2-16)
 d





         
  Stage 1 Labor, hrs 16,869 8.0  (0-24.0)
 d
 9.0  (0.1-23.4)
 d
 1.0  (-1.5, 3.4)
 e
 0.31 
  Stage 2 Labor, mins 19,393 64  (1-359)
 d
 35  (5-178)
 d
 0.9  (0.7, 1.1)
 f
 0.15 
  Stage 3 Labor, mins 19,609 5  (1-158)
 d
 4  (1-26)
 d
 0.8  (0.7, 1.0)
 f
 0.009 
      
  Multiparous Women   
   Antepartum & Intrapartum  
Labor and delivery 





Delivery Mode, n 87,042       
  Vaginal  62,612  (73.1%) 192  (52.0%)    





         
  Stage 1 Labor, hrs 17,847 5.8  (0.02-24.0)
 d
 6.8  (1.0-16.0)
 d
 0.4  (-0.9, 1.7)
 e
 0.42 
  Stage 2 Labor, mins 21,269 20  (1-360)
 d
 25  (4-155)
 d
 1.2  (0.8, 1.8)
 f
 0.18 
  Stage 3 Labor, mins 22,058 5  (1-178)
 d
 4  (1-26)
 d





         
  Stage 1 Labor, hrs 25,480 5.8  (0-24.0)
 d
 7.0  (0-23.3)
 d
 0.0  (-1.4, 1.3)
 e
 0.99 
  Stage 2 Labor, mins 29,272 19  (1-360)
 d
 17  (1-113)
 d
 1.0  (0.8, 1.2)
 f
 0.94 
  Stage 3 Labor, mins 30,677 5  (1-158)
 d
 4  (1-23)
 d




Estimates adjusted for maternal age, race, pre-pregnancy body mass index, insurance, marital status, 
cervical dilation at first exam, birthweight, gestational age, and study site; 
b
 Relative risk of cesarean 
delivery estimated with modified Poisson model; 
c 
Among vaginal deliveries; 
d 
Data are given as median, 
range; 
e
 Beta coefficient estimated with generalized linear models. Estimate is interpreted as the average 
difference in duration of stage 1 labor (in hours) for the abruption group, compared to the no abruption 
group; 
f 
Exponential of the beta coefficient estimated with generalized linear model. Estimates are 
interpreted as average labor duration (in minutes), Estimates can be interpreted as the percentage difference 
in minutes for the abruption group compared to the no abruption group where coefficients less than “1” 
represent a relative decrease and coefficients greater than “1” represent a relative increase; 
g 
Estimates are 
adjusted for maternal age, race, pre-pregnancy body mass index, insurance, marital status, cervical dilation 
at first exam, history of cesarean, birthweight, gestational age, and study site.  






Descriptive statistics and adjusted regression analyses of the neonatal outcomes 
appear in Table 4. Compared to neonates in pregnancies not complicated by abruption, 
the neonates in pregnancies complicated by abruption were more likely to need 
resuscitation in the delivery room (RR=1.54, 99% CI: 1.48, 1.61) and to be admitted to 
the NICU (RR=3.70, 99% CI: 3.51, 3.89). Among the neonates admitted to the NICU, 
abruption was also associated with a length of stay nearly twice as long (IRR= 1.98, 99% 
CI: 1.83-2.14).  Abruption was also associated with elevated risk of respiratory distress 















Newborn Resuscitation, n (%)       
  No 169,638  (77.2) 2,205  (61.0)   
  Yes 50,001  (22.8) 1,408  (39.0) 1.54  (1.48, 1.61) 
NICU Admission, n (%)       
  No 194,137  (88.4) 1,913  (53.0)   
  Yes 25,502  (11.6) 1,700  (47.0) 3.70  (3.51, 3.89) 
       
NICU LOS, days  6  (0-483)
 b
 20  (0-365)
 b
 1.98  (1.83, 2.14) 
c
 
Respiratory Distress Syndrome, n (%)       
  No 213,211  (97.1) 2,728  (75.5)   
  Yes 6,428  (2.9) 885  (24.5) 7.40  (6.77, 8.04) 
Apnea, n (%) 
d
       
  No 194,969  (97.9) 2,981  (85.5)   
  Yes 4,202  (2.1) 506  (14.5) 6.63  (5.86, 7.40) 
Asphyxia, n (%)       
  No 219,126  (99.8) 3,537  (97.9)   
  Yes 513  (0.2) 76  (2.1) 8.96  (6.06, 11.85) 
Perinatal Death, n (%)       
  No 217,852  (99.2) 3,390  (93.8)   
  Yes 1,787  (0.8) 223  (6.2) 7.29  (5.87, 8.70) 
a
 RR estimated with modified Poisson model adjusting for maternal age, race, parity, pre-pregnancy body 
mass index, insurance, marital status, and study site 
b
 Data are given as median, range among those admitted to NICU; excludes sites 4 and 8 which did not 
report NICU LOS 
c 
Incident rate ratio estimated with negative binomial model
 
d
 Excluding site 6 which did not report neonatal apnea  
e






Sensitivity Analysis: Timing of Abruption 
Abruption remained associated with elevated risk for all outcomes regardless of 
timing of the abruption, but the estimated risk varied greatly across the groups (Table 5). 
The risk of respiratory distress syndrome associated with pregnancies having both 
antepartum and intrapartum abruption was nearly twice that of the antepartum only group 
[(RR=9.47, 99% CI: 7.80, 11.14) and (RR=5.28, 99% CI: 4.30, 6.27) respectively]. A 
similar pattern was apparent for apnea [RR=8.62 (99% CI: 5.97, 11.27) and RR=4.54 
(99% CI: 3.25, 5.84) respectively]. In sum, the results of the sensitivity analysis indicated 
that abruption was associated with poor neonatal outcomes regardless of whether it 




Table 5. Analyses of neonatal outcomes according to timing of placental abruption  























Resuscitation, n (%)  
              
  No 105,916  (74.0) 619  (64.0)   497  (79.0)   190  (33.8)   
  Yes 37,138  (26.0) 348  (36.0) 1.29  (1.19, 1.39) 132  (21.0) 1.56  (1.31, 1.81) 372  (66.2) 1.43  (1.34, 1.53) 
NICU  
Admission, n (%) 
              
  No 125,988  (88.1) 597  (61.7)   316  (50.2)   268  (47.7)   
  Yes 17,066  (11.9) 370  (38.3) 2.73  (2.42, 3.04) 313  (49.8) 3.26  (2.89, 3.62) 294  (52.3) 4.99  (4.45, 5.53) 
               
NICU LOS, days  6  (0-483)
 b
 12  (0-148)
 b
 1.84  (1.52, 2.15) 
c
 22  (0-173)
 b
 2.00  (1.68, 2.33) 
c
 22  (0-181)
 b




Syndrome, n (%) 
              
  No 138,562  (96.9) 790  (81.7)   489  (77.7)   393  (69.9)   
  Yes 4,492  (3.1) 177  (18.3) 5.28  (4.30, 6.27) 140  (22.3) 6.38  (5.07, 7.69) 169  (30.1) 9.47  (7.80, 11.14) 
Apnea, n (%) 
d
               
  No 140,407  (98.2) 883  (91.3)   552  (87.8)   501  (89.1)   
  Yes 2,647  (1.8) 84  (8.7) 4.54  (3.25, 5.84) 77  (12.2) 5.86  (4.09, 7.63) 61  (10.9) 8.62  (5.97, 11.27) 
Asphyxia, n (%)               
  No 142,678  (99.7) 951  (98.4)   621  (98.7)   543  (96.6)   
  Yes 376  (0.3) 16  (1.6) 6.76  (2.17, 11.35) 8  (1.3) 5.70  (0.62, 10.77) 19  (3.4) 11.49  (4.43, 18.55) 
Perinatal Death, n (%)               
  No 141,769  (99.1) 936  (96.8)   589  (93.6)   544  (96.8)   
  Yes 1,285  (0.9) 31  (3.2) 3.29  (1.60, 4.97) 40  (6.4) 4.95  (2.84, 7.06) 18  (3.2) 5.68  (2.30, 9.06) 
a 
RR estimated with modified Poisson model adjusting for
 




 Data are given as median, range among those admitted to NICU; excludes sites 4 and 8 which did not report NICU LOS 
c
 Incident rate ratio estimated with negative binomial model 
d
 Excluding site 6 which did not report neonatal apnea 
e




Sensitivity Analysis: Direct Effects of Abruption 
To determine whether there is a direct effect attributed to abruption, beyond the 
risks associated with preterm birth, low birthweight and cesarean delivery, I conditioned 
on these intermediates with sensitivity analyses.
84
 For each variable, analyses are 
presented within each stratum and then, sensitivity analyses examining the impact of 
potential bias within the “risk” group (e.g. preterm/low birthweight/cesarean delivery) are 
presented. 
Gestational Age 
Descriptive statistics and adjusted regression analyses of the neonatal outcomes 
appear in Table 6. With the exception of NICU LOS among term deliveries, the 
association between abruption and all neonatal outcomes remained significant among 
both term and preterm birth neonates. The estimated risk of all neonatal outcomes was 
higher in the term group than the preterm group, but there were no instances of illogical 
findings among the preterm group (e.g., estimates suggesting a protective effect for 
abruption). Although there are differences in the magnitude of risk between the term and 
preterm groups, these findings indicate that abruption has a direct effect on neonatal 
outcomes not through gestational age. In other words, abruption is associated with an 
increased risk of poor neonatal outcomes beyond the risk that can be attributed to preterm 
birth. The bias-adjusted risk estimates for neonatal outcomes among the preterm neonates 
appear in Table 7. Estimated risk of neonatal outcomes increased to varying levels in all 
scenarios indicating that unmeasured causes of preterm birth in this sample may result in 
some underestimation of the risk associated with abruption for poor neonatal outcomes 
among preterm neonates. 
40 
 
Table 6. Analyses of neonatal outcomes according to abruption status among term and preterm deliveries 
 Term (n=197,155) Preterm (n=26,097) 









Newborn Resuscitation, n (%)              
  No 153,091  (78.3) 1,099  (65.1)   16,547  (68.5) 1,106  (57.4)   
  Yes 42,377  (21.7) 588  (34.9) 1.34  (1.24, 1.43) 7,624  (31.5) 820  (42.6) 1.30  (1.22, 1.37) 
NICU Admission, n (%)             
  No 181,878  (93.1) 1,438  (85.2)   12,259  (50.7) 475  (24.7)   
  Yes 13,590  (6.9) 249  (14.8) 1.97  (1.67, 2.27) 11,912  (49.3) 1,451  (75.3) 1.51  (1.45, 1.57) 
             
NICU LOS, days  3  (0-280)
 b
 4  (0-105)
 b
 0.96  (0.74, 1.19) 
c
 14  (0-483)
 b
 25  (0-365)
 b
 1.41  (1.30, 1.51)
 c
 
Respiratory Distress Syndrome, n (%)             
  No 194,247  (99.4) 1,643  (97.4)   18,964  (78.5) 1,085  (56.3)   
  Yes 1,221  (0.6) 44  (2.6) 3.45  (2.08, 4.82) 5,207  (21.5) 841  (43.7) 2.00  (1.85, 2.15) 
Apnea, n (%) 
d
             
  No 175,424  (99.5) 1,605  (98.5)   19,545  (85.4) 1,376  (74.1)   
  Yes 854  (0.5) 24  (1.5) 2.79  (1.28, 4.31) 3,348  (14.6) 482  (25.9) 1.87  (1.67, 2.07) 
Asphyxia, n (%)             
  No 195,166  (99.8) 1,667  (98.8)   23,960  (99.1) 1,870  (97.1)   
  Yes 302  (0.2) 20  (1.2) 7.52  (2.88, 12.16) 211  (0.9) 56  (2.9) 3.59  (2.18, 5.00) 
Perinatal Death, n (%)             
  No 194,907  (99.7) 1,654  (98.0)   22,945  (94.9) 1,736  (90.1)   
  Yes 561  (0.3) 33  (2.0) 8.07  (4.10, 12.04) 1,226  (5.1) 190  (9.9) 1.99  (1.61, 2.39) 
a 
RR estimated with modified Poisson model adjusting for
 




 Data are given as median, range among those admitted to NICU; excludes sites 4 and 8 which did not report NICU LOS 
c
 Incident rate ratio estimated with negative binomial model 
d
 Excluding site 6 which did not report neonatal apnea 
e














π11= Estimated prevalence of unmeasured causes of preterm birth in the abruption group 
π01= Estimate prevalence of unmeasured causes of preterm birth in the non-abruption group 
 
a
 Risk estimates are adjusted for unmeasured common causes (confounding) of preterm birth and the specified outcomes. For newborn resuscitation 
under “2.0” in the first column, the scenario is that 5% of the abruption group and 50% of the non-abruption group have unmeasured common causes 
(confounding) of preterm birth and newborn resuscitation and that these unmeasured causes result in a 2-fold increase in risk for newborn resuscitation. 
In this scenario, the original adjusted risk for newborn resuscitation was RR=1.30 and the bias factor yielded a corrected RR=1.85. 
 
  
  π11=0.05,  π01=0.50 π11=0.10,  π01=0.75 π11=0.15,  π01=0.80 
  Odds of Preterm Birth Odds of Preterm Birth Odds of Preterm Birth 
Neonatal outcome Adjusted RR 2.0 5.0 10.0 2.0 5.0 10.0 2.0 5.0 10.0 
Newborn Resuscitation  1.30  1.85  3.25  5.00  2.06  3.71  5.20  2.03  3.42  4.48  
NICU Admission 1.51 2.16 3.77 5.81 2.40 4.31 6.29 2.36 3.97 5.21 
NICU LOS 1.41  2.01  3.53  5.42  2.24  4.03  5.64  2.20  3.71  4.86  
Respiratory Distress Syndrome 2.00  2.86  5.00 7.69  3.17  5.71  8.00  3.13  5.26  6.90  
Apnea 1.87  2.67  4.68  7.19  2.97  5.34  7.48  2.92  4.92  6.45  
Asphyxia 3.59  5.13  8.98  13.81  5.70  10.26  14.36  5.61  9.45  12.38  




 Descriptive statistics and adjusted regression analyses are presented in Table 8. 
With the exception of NICU LOS among the normal birthweight group, all associations 
remained significant among both birthweight groups. The model for risk of asphyxia 
among low birthweight neonates failed to converge due to small sample sizes in some 
study sites. The risks associated with abruption were more pronounced in the non-low 
birthweight group, but there were no illogical results (e.g., protective effects) among the 
low birthweight group. These results again provide evidence that abruption has a direct 
negative effect on neonatal outcomes not through birthweight. In other words, abruption 
is associated with an increased risk of poor neonatal outcomes beyond the risk that can be 
attributed to low birthweight. Bias-adjusted risk estimates for the association between 
abruption and neonatal outcomes among low birthweight neonates appear in Table 9. 
Again, estimated risk of neonatal outcomes increased to varying levels in all scenarios 
indicating that unmeasured causes of low birthweight in this sample may result in 
underestimation of the risk associated with abruption for poor neonatal outcomes among 




Table 8. Analyses of neonatal outcomes according to abruption status among neonates without and with low birthweight 
 Non- Low Birthweight (n=204,466) Low birthweight (n=18,786) 
Neonatal Outcome No Abruption Abruption 
Relative Risk  
(99% CI) 
a, e





Newborn Resuscitation, n (%)              
  No 157,853  (78.0) 1,275  (65.1)   11,785  (68.8) 930  (56.2)   
  Yes 44,654  (22.0) 684  (34.9) 1.33  (1.24, 1.41) 5,347  (31.2) 724  (43.8) 1.31  (1.23, 1.39) 
NICU Admission, n (%)             
  No 186,748  (92.2) 1,580  (80.7)   7,389  (43.1) 333  (20.1)   
  Yes 15,759  (7.8) 379  (19.4) 2.35  (2.06, 2.64) 9,743  (56.9) 1,321  (79.9) 1.39  (1.34, 1.44) 
             
NICU LOS, days  4  (0-280)
 b
 4  (0-105)
 b
 1.08  (0.91, 1.26) 
c
 18  (0-483)
 b
 28  (0-365)
 b




Syndrome, n (%)             
  No 200,466  (99.0) 1,878  (95.9)   12,745  (74.4) 850  (51.4)   
  Yes 2,041  (1.0) 81  (4.1) 3.52  (2.50, 4.55) 4,387  (25.6) 804  (48.6) 1.88  (1.74, 2.02) 
Apnea, n (%) 
d
             
  No 181,901  (99.4) 1,848  (98.0)   13,068  (80.7) 1,133  (70.8)   
  Yes 1,083  (0.6) 38  (2.0) 3.19  (1.80, 4.58) 3,119  (19.3) 468  (29.2) 1.61  (1.44, 1.78) 
Asphyxia, n (%)             
  No 202,159  (99.8) 1,935  (98.8)   16,967  (99.0) 1,602  (96.9)   
  Yes 348  (0.2) 24  (1.2) 7.34  (3.22, 11.46) 165  (1.0) 52  (3.1) ---- ---- 
Perinatal Death, n (%)             
  No 201,913  (99.7) 1,920  (98.0)   15,939  (93.0) 1,470  (88.9)   
  Yes 594  (0.3) 39  (2.0) 8.11  (4.42, 11.79) 1,193  (7.0) 184  (11.1) 1.67  (1.33, 2.00) 
a 
RR estimated with modified Poisson model adjusting for
 




 Data are given as median, range among those admitted to NICU; excludes sites 4 and 8 which did not report NICU LOS 
c
 Incident rate ratio estimated with negative binomial model 
d
 Excluding site 6 which did not report neonatal apnea 
e






Table 9. Birthweight bias-corrected risk estimates for neonatal outcomes in the low birthweight-to-outcome pathway 
(n=18,786) 
  π11=0.05,  π01=0.50 π11=0.10,  π01=0.75 π11=0.15,  π01=0.80 
  Odds of Low Birthweight Odds of Low Birthweight Odds of Low Birthweight 
Variable RR 2.0 5.0 10.0 2.0 5.0 10.0 2.0 5.0 10.0 
Newborn Resuscitation  1.31 1.87 3.28 5.04 2.08 3.74 5.24 2.05 3.45 4.52 
NICU Admission 1.39 1.98 3.47 5.35 2.21 3.97 5.79 2.17 3.66 4.79 
NICU LOS 1.32 1.89 3.30 5.08 2.10 3.77 5.28 2.06 3.48 4.55 
Respiratory Distress Syndrome 1.88 2.69 4.70 7.23 2.98 5.37 7.52 2.94 4.95 6.48 
Apnea 1.61 2.30 4.03 6.19 2.56 4.60 6.44 2.52 4.24 5.55 
Asphyxia ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- 
Perinatal Death  1.67 2.39 4.18 6.42 2.65 4.77 6.68 2.61 4.39 5.76 
π11= Estimated prevalence of unmeasured causes of low birthweight in the abruption group 
π01= Estimate prevalence of unmeasured causes of low birthweight in the non-abruption group 
 
a
 Risk estimates are adjusted for unmeasured common causes (confounding) of low birthweight and the specified outcomes. For newborn resuscitation 
under “2.0” in the first column, the scenario is that 5% of the abruption group and 50% of the non-abruption group have unmeasured common causes 
(confounding) of low birthweight and newborn resuscitation and that these unmeasured causes result in a 2-fold increase in risk for newborn 






 Descriptive statistics and adjusted regression analyses are presented in Table 10. 
All associations between abruption and the neonatal outcomes remained significant in 
both the vaginal and cesarean delivery groups, indicating a direct negative effect of 
abruption not through mode of delivery. There were no illogical findings of protective 
effects of abruption in either group. In other words, abruption is associated with an 
increased risk of poor neonatal outcomes beyond the risk that can be attributed to 
cesarean delivery. Bias-adjusted risk estimates for the association between abruption and 
neonatal outcomes among neonates delivered via cesarean are presented in Table 11. 
Risk of neonatal outcomes increased across all scenarios indicating that unmeasured 
causes of cesarean delivery may result in underestimation of the risk associated with 




Table 10. Analyses of neonatal outcomes according to abruption status among vaginal and cesarean deliveries 
 Vaginal Delivery (n=160,788) Cesarean Delivery (n=62,464) 









Newborn Resuscitation, n (%)              
  No 124,874  (78.6) 1,109  (60.3)   44,764  (73.8) 1,096  (61.8)   
  Yes 34,076  (21.4) 729  (39.7) 1.44  (1.35, 1.53) 15,925  (26.2) 679  (38.2) 1.47  (1.37, 1.57) 
NICU Admission, n (%)             
  No 145,023  (91.2) 1,158  (63.0)   49,114  (80.9) 755  (42.5)   
  Yes 13,927  (8.8) 680  (37.0) 3.87  (3.55, 4.20) 11,575  (19.1) 1,020  (57.5) 2.66  (2.50, 2.82) 
             
NICU LOS, days  6  (0-483)
 b
 19  (0-235)
 b
 2.28  (1.99, 2.57) 
c
 7  (0-426)
 b
 21  (0-365)
 b




Syndrome, n (%)             
  No 156,048  (98.2) 1,518  (82.6)   57,163  (94.2) 1,210  (68.2)   
  Yes 2,902  (1.8) 320  (17.4) 8.33  (7.13, 9.53) 3,526  (5.8) 565  (31.8) 4.76  (4.25, 5.26) 
Apnea, n (%) 
d
             
  No 140,449  (98.5) 1,616  (89.2)   54,520  (96.2) 1,365  (81.4)   
  Yes 2,076  (1.5) 195  (10.8) 7.41  (6.00, 8.81) 2,126  (3.8) 311  (18.6) 4.55  (3.87, 5.22) 
Asphyxia, n (%)             
  No 158,710  (99.9) 1,821  (99.1)   60,416  (99.5) 1,716  (96.7)   
  Yes 240  (0.1) 17  (0.9) 5.76  (2.00, 9.51) 273  (0.5) 59  (3.3) 7.40  (4.58, 10.21) 
Perinatal Death, n (%)             
  No 157,726  (99.2) 1,703  (92.7)   60,126  (99.1) 1,687  (95.0)   
  Yes 1,224  (0.8) 135  (7.3) 9.52  (7.14, 11.89) 563  (0.9) 88  (5.0) 5.48  (3.78, 7.18) 
a 
RR estimated with modified Poisson model adjusting for
 




 Data are given as median, range among those admitted to NICU; excludes sites 4 and 8 which did not report NICU LOS 
c
 Incident rate ratio estimated with negative binomial model 
d
 Excluding site 6 which did not report neonatal apnea 
e





Table 11. Delivery mode bias-corrected risk estimates for neonatal outcomes in the cesarean-to-outcome pathway (n=62,464) 
  π11=0.05, π01=0.50 π11=0.10,  π01=0.75 π11=0.15,  π01=0.80 
  Odds of Cesarean Odds of Cesarean Odds of Cesarean 
Neonatal outcome RR 2.0 5.0 10.0 2.0 5.0 10.0 2.0 5.0 10.0 
Newborn Resuscitation  1.47 2.10 3.68 5.65 2.33 4.20 5.88 2.30 3.87 5.07 
NICU Admission 2.66 3.80 6.65 10.23 4.22 7.60 11.08 4.16 7.00 9.17 
NICU LOS 1.70 2.43 4.25 6.54 2.70 4.86 6.80 2.66 4.47 5.86 
Respiratory Distress Syndrome 4.76 6.80 11.90 18.31 7.56 13.60 19.04 7.44 12.53 16.41 
Apnea 4.55 6.50 11.38 17.50 7.22 13.00 18.20 7.11 11.97 15.69 
Asphyxia 7.40 10.57 18.50 28.46 11.75 21.14 29.60 11.56 19.47 25.52 
Perinatal Death  5.48 7.83 13.70 21.08 8.70 15.66 21.92 8.56 14.42 18.90 
π11= Estimated prevalence of unmeasured causes of cesarean in the abruption group 
π01= Estimate prevalence of unmeasured causes of cesarean in the non-abruption group 
 
a
 Risk estimates are adjusted for unmeasured common causes (confounding) of cesarean delivery and the specified outcomes. For newborn resuscitation 
under “2.0” in the first column, the scenario is that 5% of the abruption group and 50% of the non-abruption group have unmeasured common causes 
(confounding) of cesarean delivery and newborn resuscitation and that these unmeasured causes result in a 2-fold increase in risk for newborn 




Chapter 4: Discussion 
 
 
The purpose of this study was to examine the labor, delivery, and neonatal 
outcomes associated with placental abruption using a large, U.S.-based cohort with 
detailed clinical information. Specifically, I evaluated whether there were differences 
between women with placental abruption and without abruption in terms of 1) duration of 
labor and mode of delivery, 2) use of newborn resuscitation and duration of stay in the 
NICU, and 3) risk of neonatal outcomes associated with hypoxia and prematurity. This is 
the first study to examine the duration of labor (by stage) associated with abruption and 
the first study in a U.S. population to report the mode of delivery associated with 
abruption, regardless of timing or type of abruption. This is also the first study in a U.S. 
population to examine the association between abruption and neonatal morbidities 
associated with prematurity and hypoxia. 
Incidence of Abruption 
 The incidence of abruption in this sample (1.6%) was higher than previous U.S. 
reports (0.6-1%),
7,30,68,93,94
 as well as European and Asian studies (0.09- 0.9%), 
4,26,56,60,63,95
 but was lower than the reported incidence for Pakistan and India (3.5- 
4.7%).
96-100
 A likely explanation for the difference in incidence between this sample and 
other U.S. studies is that previous studies had utilized the medical record or birth 
certificate data only to identify cases, whereas in this sample, cases were identified from 
the maternal and neonatal medical records, supplemented with hospital discharge codes 
(ICD-9).
101
 Alternatively, it is also possible that the incidence of abruption has actually 
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increased over time since this study extends roughly 6 years past the latest previously 
published data in the U.S. A previous study examining incidence of abruption from 1979-
2001 in the U.S. also reported that there was an increasing trend and suggested it may be 
due to either improved diagnoses or increasing prevalence of risk factors.
55
 The 
explanation behind differences between this sample and reports coming from other 
countries are less clear, but are likely due to a combination of differences in cases 
definitions, as well as underlying population and practice differences. 
Mode of Delivery 
Pregnancies complicated by placental abruption were more likely to be delivered 
by cesarean compared to pregnancies that were not complicated by an abruption. The 
reported incidence of cesarean use in this dataset (47.9% and 51.3%, for nulliparous and 
multiparous women respectively) is lower than the two previous reports out of the U.S., 
which had ranged from 53.3% - 96%.
102,103
 However, both of these studies focused on 
higher risk subpopulations. Witlin and Sibai only included cases of abruption with greater 
than 20% detachment and excluded cases secondary to trauma, as well as those that were 
considered chronic, marginal or partial abruptions.
102
 Similarly, Allred and Batton only 
included abruptions that were accompanied by preterm birth.
104
 However, the incidence 












 and Finland (74.1-91%).
95,110
 The exceptions were estimates from 






This lower rate of cesarean delivery for abruption in my sample is not explained 
by an overall lower cesarean use: the U.S. also had the highest cesarean rate for non-
abruption deliveries (26.4-29.5%) compared to the other countries, which ranged from 
12.8% (Israel) to 27.7% (Japan).
105,106
 In developing countries, differences in access to 
health care (especially prenatal care) or inadequate access to resources at the time of 
delivery may result in more severe cases of abruption, which may necessitate a cesarean 
more often. Another explanation for discrepancies in cesarean rates may be due to 
differences in case definitions. While two of the studies did not provide details of their 
case definitions,
4,63
 those that did typically defined their cases based on symptoms 
present at the delivery (e.g. substantial blood loss, painful contractions) or presence of 
retroplacental blood clots during either clinical or pathological examination of the 
placenta.
56,60,107,110
 One study explicitly excluded mild forms of abruption that resolved.
31
 
The current sample included all cases of abruption regardless of the presence of 
symptoms or pathological findings.  
In my sensitivity analysis examining the timing of the abruption relative to labor, 
my finding of elevated use of cesarean delivery among intrapartum (37.6%- 49.2%) 
abruption cases was similar to the reported cesarean incidence of 46.9% in the only other 
study examining outcomes of abruption by timing relative to labor. On the other hand, 
my finding of elevated use of cesarean (36.8%-40.3%) among antepartum cases was 
considerably lower than their report of 65.8%.
32
 The previous study focused exclusively 
on emergency cesarean deliveries and the high incidence is likely a function of their case 
definitions, which only included instances of antepartum and intrapartum abruption that 
required emergent treatment. 
32
 In instances where abruption occurs prior to the onset of 
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labor, it may be reassuring for patients to know that the likelihood of a cesarean delivery 
may not be as high as previously reported. 
Duration of Labor 
Despite the fact that 26.1% - 30.1% of pregnancies complicated by abruption 
present with hypertonic uterine contractions,
56,60
 placental abruption was not associated 
with differences in stage 1 or stage 2 labor duration for either nulliparous and multiparous 
women, regardless of whether they presented in spontaneous labor or were induced. 
Conversely, abruption was associated with a shorter duration of stage 3 labor among 
multiparous women with spontaneous labor. However, an adjusted difference of only 
about one minute could not be considered clinically meaningful. These findings are 
largely in contrast to the two previous studies which found an elevated incidence of 
abruption among women with precipitous (<3 hrs) labor.
61,62
 When the total duration of 
labor was examined in post-hoc analysis in my sample, the overall incidence of abruption 
was nearly identical between precipitous and non-precipitous labor groups (1% and 1.1%, 
respectively).  
In contrast to the current sample which was restricted to singleton gestations, 
Mahon et al. restricted their analysis to precipitous labor occurring among singleton 
pregnancies with vertex presentation, a birthweight greater than or equal to 2500g, and a 
gestational age greater than or equal to 37 weeks.
62
 Abruption is associated with an 
incidence of low birthweight ranging from 44.7% to 61.6% 
31,105,106
 and an incidence of 
preterm birth ranging from 39.6% to 69.2%,
7,56,60,95,105,106,110,113
 therefore, Mahon et al. 
would have likely excluded many typical cases of abruption, which may partly explain 
their results. However, in a post-hoc analysis restricting my own data to a birthweight  
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greater than or equal to 2500g and a gestational age greater than or equal to 37 weeks, I 
was unable to replicate the findings of Mahon’s study: there was actually a higher 
incidence of abruption among women without precipitous labor (0.74%) compared to 
those with precipitous labor (0.47%). It is possible that underlying population risk factors 
for abruption may have been more prevalent in that sample compared to the current 
sample population. Sheiner et al. had a more comparable sample to the one used in the 
current study, but they did not stratify their models by induction and parity.
116
 In contrast, 
I modeled duration of labor as a continuous variable for all three stages and calculated 
risk separately for nulliparous and multiparous women, as well as for induced and 
spontaneous labor. This approach allows for a more clinically meaningful analysis 
because the relationship between abruption and labor duration functioned differently 
within each of these groups.  
In my sensitivity analysis examining the impact of the timing of abruption, many 
of the comparisons failed to reach statistical significance, but there were trends 
suggesting that this area may be worth further investigation. In contrast to the main 
analysis, the labor duration associated with abruption was in some cases much longer 
and, in others, much shorter depending on parity, the timing of the abruption, and 
whether the labor was spontaneous or induced. For instance, compared to women without 
an abruption, stage 1 labor duration among nulliparous women with induced labor was 
trending toward being significantly shorter for women with intrapartum abruption, and 
women with both antepartum and intrapartum abruption. In contrast, compared to women 
without an abruption, stage 1 labor duration among multiparous women with either 
induced or spontaneous labor was trending toward being significantly longer for women 
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with intrapartum abruption, but showed little to no difference for women with both 
antepartum and intrapartum abruption. Similar patterns of differences can be seen in 
stage 2 labor duration. Stage 3 labor duration was the only outcome that showed 
consistency across groups: all induced labor groups showed no significant differences 
and all spontaneous labor groups showed either significantly shorter labor or trended 
toward shorter labor. 
It may be that cases of abruption that require induction (due to maternal or fetal 
decline or due to being post-term) represent a different type of case compared to those 
that have spontaneous labor. Or, these differences may be a reflection of clinicians 
choosing more conservative management in cases of abruption (utilizing different 
induction agents or lower doses). It is also possible that cases of abruption that occur 
before the onset of labor may represent a different etiology than those that occur during 
labor. Regardless, my findings suggest that the impact of abruption on labor duration may 
not be as simple as previously thought: it seems that parity, the timing of the abruption, 
and the use of induction of labor may all play a role in the association between abruption 
and labor and delivery outcomes. Outcomes associated with abruption are likely to vary 
considerably depending on the combination of these characteristics. 
Newborn Resuscitation, NICU LOS, and Neonatal Outcomes 
 Abruption was found to be associated with elevated risk of newborn resuscitation, 
longer length of stay in the NICU, respiratory distress syndrome, asphyxia, apnea, and 
perinatal death. My finding that 39% of the neonates in deliveries with abruption required 
resuscitation in the delivery room was comparatively lower than the three previous 
studies that had examined the need for resuscitation associated with abruption, where 
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estimates ranged from 50% to 63.4%.
112,117,118
 This is likely due differences in case 
definitions: previous samples included more severe cases of abruption, whereas my 
sample likely included more mild cases of antepartum abruption that could have 
spontaneously resolved without negatively impacting the neonate. However, admission to 
the NICU (47%) and the median length of stay (20 days) were higher in my sample 
compared to previous estimates of NICU admission ranging from 20-38.2% and average 
length of stay of 8.4 days.
32,69,95
  Hasegawa et al. included mild cases of abruption, but 
their sample’s neonates had a higher average gestational age at birth compared to the 
current sample, which may have lowered their NICU admission rates.
32
 However, Ross et 
al. included abruption cases that were initially identified through patient self-report, 
which might have resulted in a recall bias (i.e. patients with poor birth outcomes would 
have been more likely to remember details of an abruption compared to patients that had 
good birth outcomes).
69
 Toivonen et al. only included severe cases, which would be 
expected to have higher, not lower NICU admission.
31
 Although there is one possible 
explanation for the difference between my results and the Hasegawa et al. study, it is 
otherwise unclear why the neonatal admission to the NICU and NICU LOS were higher 
in my sample. 
In my sample, 24.5% of neonates in pregnancies with abruption experienced 
RDS, which is substantially lower than the 40% reported by Spinillo et al.
59
 However, 
Spinillo et al. focused on low birthweight neonates only. When my sample was stratified 
by birthweight, the incidence of RDS in cases of abruption with a low birthweight 
neonate (48.6%) was actually higher than previous estimates. Although the Spinillo et al. 
sample had an average gestational age ranging from 32.9-33.9 weeks (depending on the 
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severity of the abruption), it was unclear what percentage of their cases were born 
preterm.
59
 It is possible that there were a relatively higher percentage of preterm births 
among the low birthweight neonates in my sample, which could lead to a higher 
incidence of RDS. In the second study examining the association between abruption and 
RDS, Saeed and Rana found that only 15% of the neonates experienced RDS, but there 
was also a very high perinatal mortality rate (50%).
111
  It is likely that surviving neonates 
represented less severe cases which may explain the relatively low incidence of RDS.  
Only one previous study reported the incidence of asphyxia (47.6%) among cases 
of abruption, which was substantially higher than my estimate of asphyxia (2.1%).
108
 
This relatively small (n=103) study by Pitaphrom and Sukcharoen was conducted outside 
of the U.S. and there was evidence to suggest that the abruption cases may have been of 
the more severe type.
60
 I am the first to report an elevated risk of neonatal apnea 
associated with abruption. Neonatal apnea is due to underdevelopment of respiratory 
control, most frequently as a consequence of prematurity.
119
 As abruption is frequently 
accompanied by preterm birth, an elevated risk of apnea in the context of abruption is 
plausible, but it is not clear why this association was also found among term neonates. It 
may be that abruption is independently associated with physiologic underdevelopment. 
Lastly, I found an overall incidence of perinatal mortality of 6.2%, which is lower than 
previous reports from the U.S. from the 1990’s- early 2000’s which had an estimated 
perinatal mortality of 10.3-11.9%.
94,120,121
 Perinatal mortality associated with abruption is 






 In my sensitivity analysis examining the impact of the timing of abruption, the 
association between abruption and newborn resuscitation, NICU length of stay, and 
neonatal outcomes remained significant regardless of timing, but the analysis revealed 
some important differences between groups. Generally, I found that neonates in 
pregnancies complicated with both antepartum and intrapartum abruption tended to have 
the highest risk of poor outcomes. In contrast, with the exception of asphyxia, neonates in 
pregnancies complicated with antepartum abruption had the lowest relative risk across 
outcomes. It may be that pregnancies with both antepartum and intrapartum abruption 
represent more severe disease, while my antepartum group may be reflecting more mild 
cases of abruption that spontaneously resolved during pregnancy.  
In my sample, admission to the NICU occurred in 38.3% of antepartum 
abruptions, 49.8% of intrapartum abruptions, and 52.3% of pregnancies with both 
antepartum and intrapartum abruption. The only previous study to report neonatal 
outcomes by timing of abruption relative to labor reported NICU admission in 73.7% of 
antepartum abruptions and only 21.9% of intrapartum abruptions.
32
 However, this 
discrepancy may be explained by the fact that the sample included only cases that 
required emergent treatment and did not distinguish cases that had both antepartum and 
intrapartum abruption. With the exception of NICU admission, this is the first study to 
report neonatal outcomes associated with abruption, while distinguishing the timing 
relative to labor. 
  In this sample, 53.3% of neonates in pregnancies complicated by abruption were 
born preterm, which is within estimates reported in the literature ranging from 39.6% - 
69.2%.
7,56,60,95,105,106,110,113
 In my sensitivity analysis stratifying by preterm status, 
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abruption remained a significant risk factor for newborn resuscitation and all neonatal 
outcomes regardless of gestational age, indicating that the association between abruption 
and adverse neonatal outcomes was not strictly due to being delivered preterm. However, 
despite a significant risk for NICU admission in both groups, NICU LOS was significant 
only for the preterm group. However, consistent with the literature on perinatal mortality, 
my study demonstrated that there were increased risks of poor neonatal outcomes 
associated with abruption even among term neonates.
68,121,123
  
One of the novel findings in this study was the elevated risk of RDS among term 
neonates. This disorder is primarily attributed to insufficient surfactant production and 
underdevelopment of the lungs, and most frequently occurs in preterm neonates.
124
 
However, there have been some reports of increased risk of RDS in cases of chronic 
intrauterine hypoxia and growth restriction and perhaps this mechanism is responsible in 
the case of abruption.
125
 I also found that RDS and apnea were twice as frequent among 
preterm neonates in pregnancies complicated by abruption compared to preterm 
pregnancies not complicated by abruption. It is important for clinicians to be aware of the 
increased risk of underdeveloped lung function among term neonates with abruption as 
well as elevated risk beyond that which would normally be expected for a preterm 
neonate.  
 In this sample, 45.4% of neonates in pregnancies complicated by placental 
abruption had a low birthweight, which is comparable to the reports in the literature 
ranging from 44.7% to 61.6%.
31,105,106
 In my sensitivity analysis stratifying the results by 
low birthweight status, the association between abruption and risk of newborn 
resuscitation and neonatal outcomes remained significant regardless of birthweight status, 
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indicating that the association between abruption and adverse neonatal outcomes was not 
strictly due to being low birthweight. NICU LOS was only significantly increased with 
abruption among neonates with low birthweight.  
   Although abruption remained a risk factor for all neonatal outcomes among both 
groups, it is worth noting that risk of neonatal morbidity was greatly elevated among low 
birthweight neonates in pregnancies complicated by abruption. In the abruption group, 
nearly half (48.6%) of the neonates developed RDS and 29.2% experienced apnea. In 
contrast, only 25.6% of low birthweight neonates without abruption developed RDS, and 
only 19.3% experienced apnea. This information may be useful for advising patients on 
what risks may be anticipated after delivery and also suggests potential for increased 
risks in the setting of abruption coupled with low birthweight.  
 Abruption was also associated with elevated risk of newborn resuscitation, longer 
NICU length of stay, and poor neonatal outcomes regardless of delivery mode. However, 
in the vaginal delivery group, the NICU length of stay was longer, and there was higher 
risk of RDS, apnea, and perinatal death. The interpretation of these results is more 
difficult because it depends on whether vaginal or cesarean delivery should be considered 
the optimal delivery mode. It is possible that risks in the cesarean group are 
underestimated because there are competing causes necessitating cesarean delivery, in 
which case the bias-adjusted results provide us with a range of possible estimates. It is 
also possible that vaginal delivery may be the risk group because it could prolong 




I present a large, multi-site study of 223,252 deliveries (with 3,613 cases of 
abruption), with detailed clinical data that allowed examination of less common 
outcomes, as well as the ability to adjust for a number of potential confounders. 
Additionally, this study is unique in the collection of labor information which allowed me 
to examine duration of labor by stage.  
Limitations 
The results of this study cannot be considered to be representative of the entire 
U.S. population.  This sample includes only hospital births and would therefore not be 
generalizable to births taking place at home or in birthing centers.  I utilized data from a 
retrospective, observational study of EMRs, and there was some missing outcome data, 
which slightly reduced the sample size in some instances (labor duration, apnea, NICU 
LOS).  
The duration of labor estimates only included women who delivered vaginally, as 
regression methods to examine duration of labor that include intrapartum cesarean 
deliveries while adjusting for covariates are as of yet undeveloped.
126
 Cesarean deliveries 
would have right censoring during either stage 1 or stage 2 labor (at the time the cesarean 
was performed) that would be dependent on a number of other factors not addressed in 
this study. If there were serious signs of neonatal distress or complications occurring, the 
physician may have made the decision to intervene earlier, in which case, the recorded 
duration of labor may be much shorter. Conversely, if the cesarean was performed as a 
consequence the labor progressing much slower than anticipated, the duration of labor 
might be much longer.   
60 
 
Finally, there are limitations for my sensitivity analyses examining the impact of 
the timing of abruption. Approximately half of the sites failed to report whether the 
abruption occurred before or during labor, likely due to the way that the information was 
recorded in the EMR. However, it is important to note that there was a very large 
remaining sample size (n=145,212). For those sites that did report the information, I only 
know whether the abruption occurred before or after the onset of labor, but I do not have 
more specific information in terms of gestational age (for antepartum) or exact timing in 
the labor process (for intrapartum).  It is possible that an abruption classified as 
“intrapartum” was actually an undetected antepartum abruption. However, in order to 
understand how this misclassification would affect results, I would need to know what 
outcomes are associated with verified cases of antepartum and intrapartum abruption, 
data for which are not yet available. The fact that neonates in the intrapartum category 
had the lowest average birthweight suggested that it is more likely that those cases 
represent a chronic process, but it is not clear whether it was an antepartum abruption or 
more general chronic placental malfunctioning.  
Clinical Implications 
Abruption is associated with higher risk of cesarean delivery, but it remains 
unclear whether cesarean is the optimal delivery mode when abruption occurs. However, 
determining the optimal delivery mode is not straightforward. Recently, there has been a 
growing effort to reduce the use of medically unnecessary cesarean delivery since it is a 
major surgical procedure associated with significant short- and long-term risks for both 
the mother and the neonate.
127,128
 There are certain clinical indications in which cesarean 
delivery is medically necessary, for example as a life saving measure for either the 
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mother or the neonate in the setting of a uterine rupture, but there are other circumstances 
in which cesarean delivery may be avoidable (e.g., not allowing enough time in labor 
before performing a cesarean for failed induction or failure to progress).
127
 The decision 
of whether a cesarean is indicated should be based on the balance of risks and benefits for 
both the mother and child, which includes a number of factors. In addition, the decision 
for cesarean can also be influenced by fear of legal ramifications for the physician and 
hospital if there is a poor outcome.
127
  
In the case of acute or more severe abruption, for which there is significant risk of 
blood loss for the mother and oxygen deprivation for the neonate, the benefits associated 
with cesarean delivery may outweigh the risks. However, a prospective study capturing 
detailed information about the presentation of each case (maternal and fetal symptoms, 
severity of the abruption), labor progress, the indication for the cesarean, and both short- 
and long-term maternal and neonatal outcomes would be necessary to accurately 
determine whether cesarean really is the optimal route of delivery with lesser degrees of 
abruption with no other clinical indications. 
 This study also revealed some important new information about the neonatal 
morbidities associated with abruption. This information can inform prospective parents 
about the potential risk of certain outcomes after birth, but it should be cautioned that 
these risks are also a function of the severity of the abruption, which was not captured in 
this study.  An increased risk does not mean that the event will definitely occur, only that 
there is a higher likelihood. Increased risks of apnea and respiratory distress syndrome 




Future Directions for Research 
 One potential direction of study would be a natural history or developmental 
study that captures detailed, serial measurements during pregnancy on placental 
morphology (size, thickness, location in the uterus, percentage of detachment of placenta 
when abruption occurs), Doppler measurements (to understand blood flow to and from 
the placenta and any vascular abnormalities), which can be linked with detailed 
pathological analysis of the placenta following birth.  Cumulatively, this information 
would greatly improve our understanding of how the placenta develops and changes over 
the course of pregnancy both in normal and pathological cases. Coupled with outcome 
measures (including abruption), this information may provide us with new insight into 
normal placental functioning and perhaps new and/or earlier markers for poor placental 
functioning.   
 Examining the latency period between antepartum abruption and the onset or 
induction of labor would be another area for future exploration. Determining the duration 
of time between the gestational age at which the antepartum abruption occurs, as well as 
its severity, and the gestational age at delivery would provide information about how 
often antepartum abruptions trigger contractions or necessitate medical intervention, as 
well as how much time elapses between these events. With that knowledge, we would 
have a better understanding of how often abruptions spontaneously resolve, as well as the 
conditions under which it is unlikely to resolve, and we would be better able to advise 
patients as to their prognosis for preterm labor and/or need for intervention. 
 Another direction for future research would be to evaluate the long-term 
consequences of abruption for surviving neonates. Beyond outcomes such as sudden 
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infant death syndrome and cerebral palsy, it would be interesting to determine whether 
there are long-term developmental, respiratory or other chronic disease issues in 
childhood and adulthood. It would also be informative to investigate whether the 
associated risks were different depending on whether the abruption occurred term or 
preterm, antepartum or intrapartum, as well as whether the outcomes were different 
among neonates with or without low birth weight. 
 Lastly, as there are considerable ethical issues with experimental research in 
pregnancy, another area of future study should focus on the search and development of 
animal models of more representative models of human placental disorders. Although 
animal models have proven useful for studying many other types of diseases, the human 
placenta has a combination of unusual characteristic that are not seen in any other 
species. The mouse, which is highly utilized and relatively inexpensive to maintain, has 
very shallow trophoblastic invasion of the uterine arteries (vs. the extensive invasion seen 
in humans) and a labyrinthine placental exchange area (vs. a villous area in humans).
129
 
There are certainly other differences between the mouse and human pregnancy models 
(immunological and endocrine), but these differences in the attachment type are very 
important when modeling remodeling and repair of the attachments, as well as fetal 
growth restriction.
129
 There are even placentation differences between humans and non-
human primates, including the development of the attachment between the placenta and 
the uterine wall and establishment of the maternal placental circulation. Although non-
human primates may be most similar to humans, they are less likely to become a 
commonly used animal model because of the ethical considerations that arise and because 
of the cost involve with caring for large animals with long lifespans.
129
 There are several 
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species that are under investigation, but as of now, we have not yet identified an animal 
model with the same type of placental attachment as is seen in humans. If we were able to 
successfully develop an animal model (or even a series of models for different aspects of 
placentation), it would greatly increase our understanding of placental function and 
dysfunction and would allow for investigation of potential interventions and treatments. 
Summary and Conclusions 
 In this study, I examined labor, delivery and neonatal outcomes associated with 
placental abruption. I found that abruption was associated with elevated risk of cesarean 
delivery and shorter duration of stage 3 labor duration among multiparous women with 
spontaneous labor; however, the difference in duration was only about one minute and 
was not clinically meaningful. The main analysis results, in combination with the 
sensitivity analyses, revealed that the relationship between abruption and labor duration is 
more complicated than previously reported and is likely variable depending on parity, the 
presence or absence of induction of labor, as well as the timing of the abruption relative 
to labor.  
I also found that abruption was associated with an elevated risk of newborn 
resuscitation, NICU admission and longer LOS, apnea, asphyxia, respiratory distress 
syndrome, and perinatal mortality. According to the results of this study, abruption was 
associated with elevated risk beyond the initial delivery period, and these risks were not 
solely attributable to an association with preterm birth, low birth weight, or cesarean 
delivery.  
This is the first study to examine labor duration associated with abruption and is 
the largest study in a U.S. population to examine the association between abruption and 
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cesarean delivery. I am also the first to report an increased risk of apnea among cases of 
abruption and the first to report the incidence and risk of newborn resuscitation, NICU 
length of stay (LOS), RDS, and asphyxia in cases of abruption in the U.S. Additionally, 
with the exception of NICU admission, I am the first to report associations between 
neonatal morbidity and mortality separately for antepartum and intrapartum abruption , 
which represents an important step forward for understanding the consequences of this 
disorder. Lastly, I am the first to report neonatal morbidities associated with abruption 
separately by gestational age and birthweight, which provided valuable clinical 
information about the unique risks associated with abruption for term, preterm, low 
birthweight and non-low birthweight groups. 
 In conclusion, although relatively rare, placental abruption is associated with 
elevated risk of cesarean delivery, as well as neonatal risks that can extend beyond the 
immediate birth period. These findings add to the burgeoning literature highlighting the 






Appendix A.1 Original Coding of Variables Included in Current Study 
Variable Source Original Coding 








Marital status Demographics Married 
Not married: divorced/widowed 
Not married: single 
Unknown 
Missing 






Maternal Age (years) Demographics Duration between birthdate and 
date of delivery 




Parity Reproductive History Continuous variable 
Pre-pregnancy body mass 
index (BMI) (kg/m2) 
Medical History Continuous variable 







Number of fetuses Prenatal history of 
current pregnancy 
Continuous variable 
Date/time of spontaneous 
onset of labor 
Admission to L&D  Date-time 
Cervical dilation at first 
exam (cm) 
Labor & Delivery Continuous variable 











Variable Source Original Coding 
Date/time of induction of 
labor 
Labor & delivery Date-time 
Date/time of complete 
dilation 
Labor & delivery Date-time 
Date/time of delivery Labor & delivery Date-time 
Date/time of placental 
delivery 
Labor & delivery Date-time 






ICD-9 code for abruption Discharge codes No 
Yes 








Birthweight (grams) Newborn information Continuous variable 
NICU admission Newborn information No 
Yes 
NICU length of stay (days) Newborn information Continuous variable 

























 For checkbox type items in data collection, an outcome was recorded as ‘yes’ if the box was checked. For 
the sites that reported that variable, an unchecked box was considered as “no” or “unknown.”  However, in 
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the case of all three affected variables, it would be highly unlikely for these events to go unrecorded.  
Therefore, unchecked boxed will generally be interpreted as the absence of the specified variable. If a site 
did not report a particular variable, then the entire variable was coded as missing for that site.  
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Appendix A.2 Summary Table of Study Variables 
Variable Name D.V.  I.V.  C.  
Objective 1: Determine whether the duration of labor and the mode of delivery are 
different among women with placental abruption compared to women without 
abruption.   
Placental abruption  X  
Duration of labor (stage 1) X   
Duration of labor (stage 2) X   
Duration of labor (stage 3) X   
Delivery Mode  X   
- Vaginal    
- Cesarean    
Cervical dilation at first exam   X 
Induction of labor 
a
   X 
- No    
- Yes    





  X 
Gestational age   X 
Birthweight   X 
Race   X 
- White/non-Hispanic    
- Black/non-Hispanic    
- Hispanic    
- Asian/Pacific Islander    
- Multi-racial/Other    
Insurance   X 
- Private    
- Public    
- Self-pay/Other    
Marital status   X 
- Single    
- Married    
Pre-pregnancy BMI   X 
History of cesarean delivery   X 
Study site    
Objective 2 & 3: Determine whether the use of newborn resuscitation, neonatal 
admission to and duration of stay in the NICU, and neonatal outcomes are different 
among women with placental abruption compared to women without abruption.   
Variable Name D.V.  I.V.  C.  
Placental abruption  X  
NICU length of stay (LOS) X   
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Variable Name D.V.  I.V.  C.  
Dichotomous Variables    
Newborn resuscitation required X   
NICU admission X   
Respiratory distress syndrome X   
Hypoxic-Ischemic Encephalopathy 
b
 X   
Apnea X   
Asphyxia X   
Perinatal (stillbirth + neonatal) Mortality X   
Maternal age   X 
Parity   X 
- Nulliparous    
- Multiparous    
Gestational age 
c 
    
Birthweight 
c
    
Mode of delivery 
c
   X 
- Vaginal    
- Cesarean    
Race   X 
- White/non-Hispanic    
- Black/non-Hispanic    
- Hispanic    
- Asian/Pacific Islander    
- Multi-racial/Other    
Insurance   X 
- Private    
- Public    
- Self-pay/Other    
Marital status   X 
- Single    
- Married    
Pre-pregnancy BMI   X 
Study site   X 
D.V.= Dependent Variable, I.V. = Independent Variable, C.= Covariate 
a
 Stratification variables 
b
 Subsequently dropped from analysis due to too few cases 
c







Appendix B.1 Original and imputed overall pregnancy characteristics (n=223,252) 
Pregnancy sample characteristics Original Data
 a
 Imputed Values 
Maternal Age, years 
b
 27.6  ± 6.2 27.6  ± 6.2 
      Missing, n (%) 239  (0.1)   
Maternal Race, n (%)     
  White 110,447  (51.6) 115,788  (51.9) 
  Black 50,233  (23.5) 52,461  (23.5) 
  Hispanic 39,037  (18.2) 40,155  (18.0) 
  Asian 9,207  (4.3) 9,417  (4.2) 
  Multi/Other 5,295  (2.5) 5,431  (2.4) 
      Missing, n (%) 9,033  (4.1)   
Pre-pregnancy BMI 
b
 25.4  ± 6.2 25.7  ± 6.6 
     Missing, n (%) 74,855  (33.5)   
Insurance, n (%)     
  Private 124,865  (62.4) 138,563  (62.1) 
  Public 72,130  (36.1) 80,910  (36.2) 
  Self-pay/Other 2,980  (1.5) 3,779  (1.7) 
      Missing, n (%) 23,277  (10.4)   
Marital Status, n (%)     
  Single 84,999  (39.3) 87,980  (39.4) 
  Married 131,177  (60.7) 135,272  (60.6) 
      Missing, n (%) 7,076  (3.2)   
Parity, n (%)      
  Nulliparous 88,975  (39.9)   
  Multiparous 134,277  (60.2)   
History of Cesarean 
c
, n (%)     
  No 90,724  (74.8) 102,882  (76.6) 
  Yes 30,622  (25.2) 31,395  (23.4) 
      Missing, n (%) 12,931  (9.6)   
Cervical Dilation at first exam, cm 
b
 3.2  ± 2.1 3.1  ± 2.1 
     Missing, n (%) 46,804  (21.0)   
Induction of Labor, n (%)     
  No 146,124  (65.5)   
  Yes 77,128  (34.6)   
Birthweight, grams 
b
 3,244  ± 606 3242  ± 610 
      Missing, n (%) 2,468  (1.1)   
Gestational Age, weeks 
b
 38.3  ± 2.4   
a
 Descriptive statistics prior to imputation are reported as percentages within non-missing data; the missing 
percentage is reported out of all data 
b
 Data are given as mean ± SD 
c





Appendix C.3s Maternal, Pregnancy, and neonatal characteristics according to timing of 


















(n=562) P value 
d
 
Maternal age, years 
b
  27.8  ± 6.2 27.3  ± 6.2 27.6  ± 6.2 27.7  ± 6.0 0.03 
Maternal race, n (%)          
  White 73,862  (51.6) 472  (48.8) 152  (24.2) 398  (70.8) <0.001 
  Black 33,673  (23.5) 327  (33.8) 294  (46.7) 68  (12.1)  
  Hispanic 26,619  (18.6) 132  (13.7) 153  (24.3) 77  (13.7)  
  Asian 4,663  (3.3) 17  (1.8) 9  (1.4) 16  (2.9)  
  Multi/Other 4,237  (3.0) 19  (2.0) 21  (3.3) 3  (0.5)  
Pre-pregnancy BMI 
b
 25.6  ± 6.4 26.4  ± 7.0 26.6  ± 7.3 24.9  ± 5.8 <0.001 
Insurance, n (%)          
  Private 87,544  (61.2) 492  (50.9) 231  (36.7) 363  (64.6) <0.001 
  Public 53,013  (37.1) 461  (47.7) 387  (61.5) 197  (35.0)  
  Self-pay/other 2,497  (1.8) 14  (1.4) 11  (1.8) 2  (0.4)  
Marital status, n (%)          
  Single 54,578  (38.2) 473  (48.9) 373  (59.3) 160  (28.5) <0.001 
  Married 88,476  (61.8) 494  (51.1) 256  (40.7) 402  (71.5)  
Parity, n (%)          
  Nulliparous 57,447  (40.2) 320  (33.1) 210  (33.4) 193  (34.3) <0.001 
  Multiparous 85,607  (59.8) 647  (66.9) 419  (66.6) 369  (65.7)  




3.1  ± 2.1 2.9  ± 2.3 2.8  ± 2.3 2.9  ± 2.3 <0.001 
History of Cesarean, n (%) 
c
          
  No 65,408  (76.4) 475  (73.4) 292  (69.7) 293  (79.4) 0.002 
  Yes 20,199  (23.6) 172  (26.6) 127  (30.3) 76  (20.6)  
Induction of Labor, n (%)          
  No 88,379  (61.8) 703  (72.7) 457  (72.7) 475  (84.5) <0.001 
  Yes 54,675  (38.2) 264  (27.3) 172  (27.3) 87  (15.5)  
Birthweight, grams 
b
  3260  ± 594 2695  ± 867 2361  ± 984 2478  ± 882 <0.001 
Gestational age, weeks 
b
  38.4  ± 2.2 34.4  ± 4.7 34.4  ± 4.9 34.9  ± 4.3 <0.001 
a
 Antepartum abruption are cases that occurred prior to the onset of labor, intrapartum abruption are cases 
that occurred during labor and the combined group are those who had abruption documented both before 
and during labor; 
b 
Data are given as mean ± SD;  
c 
Among multiparous women; 
d 
Significance values for 




Appendix C.6s Maternal, pregnancy, and neonatal characteristics according to abruption 
status among term and preterm deliveries 
 Term (n=197,155)  Preterm (n=26,097)  
 No Abruption Abruption P value No Abruption Abruption P value 
Maternal Age, years 
a
  27.6  ± 6.1 27.8  ± 6.2 0.37 27.5  ± 6.6 27.4  ± 6.4 0.57 
Maternal Race, n (%)           
  White 103,841  (53.1) 836  (49.6) <0.001 10,268  (42.5) 843  (43.8) 0.001 
  Black 43,267  (22.1) 491  (29.1)  8,015  (33.2) 688  (35.7)  
  Hispanic 35,145  (18.0) 272  (16.1)  4,430  (18.3) 308  (16.0)  
  Asian 8,556  (4.4) 69  (4.1)  754  (3.1) 38  (2.0)  
  Multi/Other 4,659  (2.4) 19  (1.1)  704  (2.9) 49  (2.5)  
Pre-pregnancy BMI 
a
 25.6  ± 6.5 25.8  ± 6.6 0.37 26.4  ± 7.1 26.1  ± 6.9 0.10 
Insurance, n (%)           
  Private 124,062  (63.5) 905  (53.6) <0.001 12,701  (52.6) 895  (46.5) <0.001 
  Public 68,223  (34.9) 762  (45.2)  10,935  (45.2) 990  (51.4)  
  Self-pay/Other 3,183  (1.6) 20  (1.2)  535  (2.2) 41  (2.1)  
Marital Status, n (%)           
  Single 74,386  (38.1) 727  (43.1) <0.001 11,831  (49.0) 1,036  (53.8) <0.001 
  Married 121,082  (61.9) 960  (56.9)  12,340  (51.0) 890  (46.2)  
Parity, n (%)           
  Nulliparous 117,564  (60.1) 1,096  (65.0) <0.001 14,392  (59.5) 1,225  (63.6) <0.001 
  Multiparous 77,904  (39.9) 591  (35.0)  9,779  (40.5) 701  (36.4)  
Birthweight, grams 
a
  3369  ± 452 3199  ± 484 <0.001 2327  ± 765 1,788  ± 744 <0.001 
Gestational Age, weeks 
a
  39.0  ± 1.1 38.6  ± 1.2 <0.001 33.6  ± 3.2 31.2  ± 3.9 <0.001 
a 
Data are given as mean ± SD; 
b




Appendix C.8s Maternal, pregnancy, and neonatal characteristics according to abruption 
status among neonates without and with low birthweight 
 Non- Low Birthweight 
(n=204,466) 
 Low birthweight 
(n=18,786) 
 
 No Abruption Abruption P Value No Abruption Abruption P Value 
Maternal Age 
a
  27.6  ± 6.1 27.9  ± 6.2 0.10 27.1  ± 6.7 27.2 ± 6.5 0.25 
Maternal Race, n (%)           
  White 107,603  (53.1) 992  (50.6) <0.001 6,506  (38.0) 687 (41.5) <0.001 
  Black 44,866  (22.2) 544  (27.8)  6,416  (37.4) 635 (38.4)  
  Hispanic 36,527  (18.0) 321  (16.4)  3,048  (17.8) 259 (15.7)  
  Asian 8,717  (4.3) 79  (4.0)  593  (3.5) 28 (1.7)  
  Multi/Other 4,794  (2.4) 23  (1.2)  569  (3.3) 45 (2.7)  
Pre-pregnancy BMI 
a
 25.6  ± 6.5 25.9  ± 6.6 0.12 26.0  ± 7.0 26.0 ± 7.0 0.92 
Insurance, n (%)           
  Private 128,327  (63.4) 1,068  (54.5) <0.001 8,436  (49.2) 732 (44.3) <0.001 
  Public 70,838  (35.0) 862  (44.0)  8,320  (48.6) 890 (53.8)  
  Self-pay/Other 3,342  (1.7) 29  (1.5)  376  (2.2) 32 (1.9)  
Marital Status, n (%)           
  Single 76,992  (38.0) 835  (42.6) <0.001 9,225  (53.8) 928 (56.1) 0.08 
  Married 125,515  (62.0) 1,124  (57.4)  7,907  (46.2) 726 (43.9)  
Parity, n (%)           
  Nulliparous 122,711  (60.6) 1,298  (66.3) <0.001 9,245  (54.0) 1,023 (61.9) <0.001 
  Multiparous 79,796  (39.4) 661  (33.7)  7,887  (46.0) 631 (38.1)  
Birthweight 
a
  3369  ± 435 3179  ± 441 <0.001 1910  ± 568 1580 ± 593 <0.001 
Gestational Age 
a
  38.8  ± 1.4 38.0  ± 1.9 <0.001 33.5  ± 4.1 30.8 ± 4.1 <0.001 
a 




Appendix C.10s Maternal, pregnancy, and neonatal characteristics according to 
abruption status among vaginal and cesarean deliveries 
 Vaginal Delivery 
(n=160,788) 
 Cesarean Delivery 
(n=62,464) 
 
 No Abruption Abruption P Value No Abruption Abruption P Value 
Maternal Age 
a
  27.1  ± 6.0 26.8  ± 6.0 0.06 29.0  ± 6.4 28.4  ± 6.6 <0.001 
Maternal Race, n (%)           
  White 85,657  (53.9) 947  (51.5) <0.001 28,452  (46.9) 732  (41.2) <0.001 
  Black 35,236  (22.2) 537  (29.2)  16,046  (26.4) 642  (36.2)  
  Hispanic 27,786  (17.5) 283  (15.4)  11,789  (19.4) 297  (16.7)  
  Asian 6,616  (4.2) 40  (2.2)  2,694  (4.4) 67  (3.8)  
  Multi/Other 3,655  (2.3) 31  (1.7)  1,708  (2.8) 37  (2.1)  
Pre-pregnancy BMI 
a
 24.8  ± 6.1 25.0  ± 6.5 0.77 27.8  ± 7.2 27.0  ± 6.9 <0.001 
Insurance, n (%)           
  Private 99,753  (62.8) 903  (49.1) <0.001 37,010  (61.0) 897  (50.5) <0.001 
  Public 56,327  (35.4) 902  (49.1)  22,831  (37.6) 850  (47.9)  
  Self-pay/Other 2,870  (1.8) 33  (1.8)  848  (1.4) 28  (1.6)  
Marital Status, n (%)           
  Single 62,242  (39.2) 884  (48.1) <0.001 23,975  (39.5) 879  (49.5) <0.001 
  Married 96,708  (60.8) 954  (51.9)  36,714  (60.5) 896  (50.5)  
Parity, n (%)           
  Nulliparous 97,135  (61.1) 1,209  (65.8) <0.001 34,821  (57.4) 1,112  (62.6) <0.001 
  Multiparous 61,815  (38.9) 629  (34.2)  25,868  (42.6) 663  (37.4)  
Birthweight 
a
  3263  ± 539 2553  ± 898 <0.001 3232  ± 717 2337  ± 987 <0.001 
Gestational Age 
a
  38.5  ± 2.0 35.2  ± 4.6 <0.001 38.0  ± 2.7 34.1  ± 4.9 <0.001 
a 








Advanced Maternal Age Maternal age >35 at time of pregnancy 
  
Advanced Resuscitation Resuscitation beyond basic techniques- includes tracheal 
intubation, cardiac defibrillation and administration of 
medications 
  
Amniotic Fluid Protective liquid contained within amniotic sac of pregnant 
female 
  
Anemia  Lack of sufficient healthy red blood cells to carry sufficient 
oxygen to tissue 
  
Antepartum Before Labor 
  
Apgar Scores Score representing health of newborn immediately after 
birth: Appearance, Pulse, Grimace, Activity, Respiration. 
Frequently assessed/recorded at 1 minute and 5 minutes after 
birth; Ranges from 0-10, with scores 7+ considered normal 
(add info on interpretation) 
  
Apnea Suspension of external breathing (no movement of muscles 
for inhaling and no volume change of lungs) 
  
Artificial Rupture of 
Membranes (AROM) 
A technique for inducing or augmenting labor; Puncturing 
the amniotic membrane with a tool; this allows the amniotic 
fluid to drain, which stimulates uterine contractions; this is 
in contrast to spontaneous rupture of membranes in which 
the membrane breaks on it's own during the labor process 
  
Assisted Ventilation a method to assist or replace spontaneous breathing; 
examples include air being pushed into the lungs by a 
medical professional using a bag/bellows or with a 







Non-invasive resuscitation techniques includes 
cardiopulmonary resuscitation, bag-mask ventilation, 
oxygen supplementation 
  
Birth Asphyxia a medical condition that occurs when a neonate’s brain and 
other organs do not get enough oxygen before, during or 
immediately after; the oxygen deprivation occurs long 
enough to cause physical damage- most frequently to the 
brain 
  
Birthweight: Appropriate for 
Gestational Age (AGA) 
Measurement based on estimated gestational age, gender and 
what birthweight is considered normal for the timing of 
delivery; appropriate weight for a full-term infant is between 
2,500-4,000 grams 
  
Birthweight: Large for 
Gestational Age (LGA) 
Typically a birthweight, length or head circumference that 
lies about 90th percentile for the gestational age 
  
Birthweight: Small for 
Gestational Age (SGA) 
Neonates born smaller than normal for the gestational age- 
typically weight below the 10th percentile; also sometimes 
referred to as growth restriction 
  
Cardiovascular Disease Generally refers to disease of the heart and blood vessels, 
frequently due to atherosclerosis (plaque builds up on walls 
of arteries); heart attacks, ischemic stroke, heart failure, 
arrhythmia, heart valve problems and stroke 
  
Chorioamnionitis inflammation of fetal membranes (amnion and chorion) due 
to bacterial infection 
  
Chronic Kidney Disease Includes conditions damaging the kidneys or decreasing 
their ability to function properly; can be caused by diabetes, 
high blood pressure or other disorders; can progress to 
kidney failure which will require either dialysis or 
transplantation 
  
Chronic Lung Disease In infants, typically damaged tissue in the lungs which can 
then trap air or collapse, filling with fluid; also known as 
bronchopulmonary dysplasia; generally a term for long-term 
respiratory problems in premature neonates; can also refer to 
asthma and chronic obstructive pulmonary disease (chronic 
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bronchitis and emphysema) 
  
Coagulation Disorder A disorder dealing with the body's ability to control blood 
clotting; hemophilia is the most common coagulation 
disorder (body bleeds for an extended period of time before 
clotting) 
  
Coronary Artery Disease Disease in which plaque buildings up inside the coronary 




Disease in which proteins that control blood clotting become 
over-active; small blood clots can form and cut off blood 
supply to organs; it also leads to the clotting factors being 
used up too quickly, which can then lead to uncontrolled 
bleeding 
  
Dysfibrinogenemia Typically inherited abnormality that results in defective 
fibrin clot formation, which can lead to bleeding 
complications 
  
Emergency Hysterectomy Emergency removal of the uterus - typically necessitating 
due to uncontrolled bleeding of the uterus 
  
Endocrine system Glands that secrete hormones directly into the circulatory 
system  
  
Endometrium Inner mucous membrane of the mammalian uterus 
  
Fetal Death Spontaneous intrauterine death of a fetus at any time during 
pregnancy, but typically refers to fetal death prior to 20 
weeks gestation; also sometimes termed 'stillbirth' 
  
Fetal Distress Presence of signs before or during childbirth that suggest 
fetus is not well; typical signs are decreased movement; 
meconium in the amniotic fluid; abnormally fast or slow 
heart rate, decreased variability in the heart rate, metabolic 




Fetal Membrane Consist of chorion, amnion, yolk sac and allantois 
  
Fetal Viability Ability of the fetus to survive outside of the uterus; in the 
US, it is typically considered 23-24 weeks of gestation 
  
Fibrinogen a glycoprotein in vertebrates that helps form blood clots 
  
First Stage of Labor Duration of time from the start of labor contractions to full 
dilation of the cervix (10 cm) 
  
First Trimester of Pregnancy 0-13 weeks of gestation 
  
Growth Restriction A fetus that is smaller than it should be due to abnormal 
growth rate; typically it is a neonate that is smaller than 90% 
of neonates at the same gestational week 
  
Hypertension high blood pressure (>140/90mmHg). Chronic/pre-existing 
hypertension is disease existing prior to the start of 
pregnancy 
  
Hypofibrinogenemia Deficiency of fibrinogen 
  
Hypoxia Condition in which body or region of body is deprived of 




Evidence of acute of sub-acute brain injury due to asphyxia; 
also called perinatal asphyxia 
  
Induction of Labor Artificially starting the process of labor through one of 
several methods including AROM, separating the amniotic 
sac from wall of uterus ('stripping the membranes'), 
mechanical dilation, and medications like Pitocin 
  




Intraventricular Hemorrhage Bleeding into the fluid-filled areas (ventricles) of the brain; 
most frequently occurs in neonates that are born premature; 
primarily due to the under-developed, fragile blood vessels 
  
Low Birthweight birthweight <2,500 g or 5lbs, 8 ounces 
  
Miscarriage Spontaneous loss of fetus before 20 weeks of pregnancy; 
sometimes also referred to as stillbirth or fetal death 
  
Multiparous Having had at least one previous pregnancy carried to a 
viable gestational age; multiparous women are delivering 
their second (or higher) baby 
  
Neonatal Death Death of a neonate any time after birth during the first 28 
days of life 
  
Non-Reassuring Fetal Heart 
Tracing (NRFHT) 
A fetal heartbeat pattern that signals that the neonate may be 
in distress of some sort; typical non-reassuring patterns 
include tachycardia (heart beating too fast), bradycardia 
(heart beating too slow), and late decelerations of heart rate 
associated with uterine contractions 
  
Parity The number of pregnancies carried to a viable gestational 
age 
  
Perinatal Mortality Death of a fetus or neonate (still birth + neonatal death) 
  
Placenta Previa A placental disorder in which the placenta is either partially 
or completely overlapping the internal cervical opening of 
the uterus (os)- which obstructs the neonate from being 
delivered vaginally; often requires a cesarean delivery 
  
Placental Abruption Premature separation of the placenta prior to delivery 
  





Post-partum Hemorrhage Excessive blood loss after birth; leading cause of maternal 
mortality worldwide 
  
Preeclampsia Development of high blood pressure and protein in the urine 




High blood pressure that develops after 20 weeks of 
gestation and resolves after delivery; also called 'gestational 
hypertension'; can co-occur with chronic hypertension 
  
Premature Rupture of 
Membranes (PROM) 
Rupture of the membrane after 37 weeks of gestation, but 
before the onset of labor; preterm PROM (PPROM) is the 
same rupturing prior to 37 weeks gestation; prolonged 
rupture of membranes is rupture more than 24 hours before 
the onset of labor 
  
Preterm Birth Birth prior to 37 weeks of gestation 
  
Nulliparous Having had no previous pregnancies carried to a viable 
gestational age 
  
Respiratory Distress Syndrome Breathing disorder affecting newborns- typically those born 
prematurely; in these cases, the lungs are not able to make 
enough surfactant which is a liquid that coats the inside of 
the lungs and allows the infant to breath- without it, the 
lungs collapse 
  
Second Stage of Labor Duration of time from when the cervix has fully dilated to 
10 cm until the neonate has been delivered 
  
Second Trimester of Pregnancy 14-26 weeks of gestation 
  
Stillbirth Fetal death occurring after 20 weeks of gestation 
  
Sudden Infant Death Syndrome 
(SIDS) 
Unexplained death, usually during sleep, of a seemingly 




Surfactant a liquid made by the lungs that coats the inside of the lungs 
and allows infants to breath after being born- too little leads 
to lungs collapsing  
  
Tetanic Uterus When the uterine contractions are so frequent that the 
muscles are in a constantly contracted state 
  
Third Stage of Labor Duration of time from when the neonate has been delivered 
until the placenta has been delivered 
  
Third Trimester of Pregnancy 27-40 weeks of gestation 
  
Threatened Miscarriage Any vaginal bleeding other than spotting during early stages 
of pregnancy 
  
Thrombocytopenia Low platelet count (the component that helps blood to clot) 
  
Thrombophilia An increased tendency to form abnormal blood clots in 
blood vessels 
  
Trophoblast Cells that form the outer layer of the blastocyst which 
provide nutrients to the embryo and develop into a large part 
of the placenta 
  
Uterine Hypertonicity A series of single contractions lasting 2 minutes or more or 
contraction frequency of 5 or more in 10 minutes (uterus is 
contracting too much) 
  
Vasoconstriction narrowing of the blood vessels resulting from contraction of 
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